Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
AP-1 transcription factor network	8/70	3.4979964281304013E-4	0.5281974606476906	0	0	4.571428571428571	36.380114361133536	ATF2;TCF7L2;ELF1;CREB1;DMTF1;MYB;CTNNB1;HIF1A
Signaling events regulated by Ret tyrosine kinase	6/39	3.835197036171375E-4	0.2895573762309388	0	0	6.153846153846154	48.40688960046071	CREB1;PIK3CA;IRS1;GRB10;GAB1;FRS2
Basal cell carcinoma	7/55	4.2061290439478725E-4	0.21170849521204294	0	0	5.09090909090909	39.575696945256	TCF7L2;FZD3;FZD5;HHIP;LEF1;CTNNB1;GLI3
Adipogenesis	11/133	5.194372578446371E-4	0.1960875648363505	0	0	3.308270676691729	25.0196721254818	RB1;NCOA2;CREB1;IRS1;IRS4;EBF1;SPOCK1;CTNNB1;LIFR;PRLR;HIF1A
Transcriptional regulation of white adipocyte differentiation	8/77	6.697013354290692E-4	0.2022498032995789	0	0	4.1558441558441555	30.373729716279165	MED23;NCOA2;MED13;CHD9;NCOA3;EBF1;NR2F2;MED4
Adherens junction actin cytoskeletal organization	5/29	6.918757149828902E-4	0.1741220549373607	0	0	6.8965517241379315	50.180029111054964	CDH6;CTNND1;CDH11;CTNNB1;CDH7
Wnt signaling pathway and pluripotency	9/98	7.793470088722412E-4	0.16811628334244058	0	0	3.673469387755102	26.29121935229659	TCF7L2;FZD3;FZD5;CTNND1;ESRRB;LEF1;CTNNB1;ZBTB33;MAP3K7
FGF signaling pathway	7/61	7.951619790035321E-4	0.15008682353691669	0	0	4.590163934426229	32.75983804473788	PIK3CA;FGF19;CTNND1;GAB1;SPRY2;FRS2;IL17RD
Circadian rhythm	7/62	8.773856486431346E-4	0.14720581438345925	0	0	4.516129032258064	31.787062891850365	ATF2;NCOA2;CREB1;CHD9;NCOA3;RORB;HIF1A
Cell junction organization	8/84	0.0011921825256332765	0.18001956137062475	0	0	3.8095238095238093	25.645598462972284	ITGB1;CDH6;CTNND1;CDH11;CTNNB1;PARVA;CLDN2;CDH7
N-cadherin signaling events	5/34	0.0014630597586829306	0.20083820323738408	0	0	5.88235294117647	38.39544300650074	GRIA2;FER;PIK3CA;CTNND1;CTNNB1
E-cadherin keratinocyte pathway	4/21	0.0016471077800394765	0.2072610623216341	0	0	7.619047619047619	48.828452493024685	PIK3CA;CTNND1;CTNNB1;AJUBA
Neural crest differentiation	8/91	0.001997670561670906	0.23203711908638985	0	0	3.5164835164835164	21.857665042283042	ITGB1;CDH6;FZD3;FGF19;MYB;CTNNB1;ISL1;CDH7
Incretin biosynthesis, secretion, and inactivation	4/23	0.0023425796244436227	0.2526639452078479	0	0	6.956521739130435	42.13219167446808	TCF7L2;CTNNB1;PAX6;ISL1
Adherens junction cell adhesion	7/74	0.0024850933195517504	0.2501660608348762	0	0	3.7837837837837838	22.693035388645278	TJP1;TCF7L2;FER;CTNND1;LEF1;CTNNB1;MAP3K7
Neuroactive ligand-receptor interaction	15/272	0.0036743564543548837	0.34676739037974214	0	0	2.205882352941176	12.367008697307911	GABRA2;GRIA2;LHCGR;CHRNB3;PTGER3;LPAR4;PRLR;GRM3;GLRA2;CYSLTR2;CALCR;S1PR3;DRD1;F2RL2;GRIA4
BMP receptor signaling	5/42	0.0037982815454921017	0.3373767725701808	0	0	4.761904761904761	26.539078759070478	BMPR2;BAMBI;SOSTDC1;SMAD9;MAP3K7
Melanogenesis	8/101	0.0038291605673186815	0.3212240253695116	0	0	3.168316831683168	17.632030646607024	TCF7L2;FZD3;KITLG;CREB1;FZD5;LEF1;CTNNB1;GNAI1
CARM1 transcriptional regulation by protein methylation	3/14	0.004603033511907417	0.36582003173579997	0	0	8.571428571428571	46.12319771763762	CREB1;PRKAR1A;NCOA3
Developmental biology	20/420	0.004736217280429411	0.3575844046724205	0	0	1.9047619047619047	10.195269531397654	ITGB1;NCOA2;CNTN6;CHD9;SEMA3A;NCOA3;EBF1;PAX6;NR2F2;ANK3;LAMC1;MED4;MED23;MED13;CREB1;CTNNB1;SCN7A;COL6A6;PTF1A;SRGAP1
Cell-cell communication	9/129	0.0051619269188560085	0.37116712607012253	0	0	2.7906976744186043	14.697056749704897	CDH6;ITGB1;PIK3CA;CTNND1;CDH11;CTNNB1;PARVA;CLDN2;CDH7
Neuronal system	15/283	0.005282032059535408	0.362539473177203	0	0	2.1201413427561837	11.116843241433912	GABRA2;GRIA2;CHRNB3;KCND2;KCNH7;STX7;CACNA1A;SLC6A1;GNAI1;NCALD;CREB1;GNG2;KCNK1;SLC18A2;GRIA4
Validated nuclear estrogen receptor beta network	3/15	0.005648024777015824	0.37080510492582147	0	0	8.0	41.41159513548328	SMARCE1;NCOA2;NCOA3
Inactivation of GSK3 by Akt causes accumulation of beta-catenin in alveolar macrophages	4/30	0.006317508693985948	0.39747658866328256	0	0	5.333333333333333	27.01029516014832	PIK3CA;LEF1;CTNNB1;DKK1
HES/HEY pathway	5/48	0.0067673334453859715	0.40874694010131263	0	0	4.166666666666667	20.815200615542235	RB1;HEY1;MYB;PTF1A;HIF1A
Post-translational regulation of adherens junction stability and disassembly	5/48	0.0067673334453859715	0.39302590394356984	0	0	4.166666666666667	20.815200615542235	CTNND1;IGF2;ADAM10;CTNNB1;ZBTB33
Hypothetical network for drug addiction	4/32	0.007971195406910945	0.44579648386798243	0	0	5.0	24.159604045535342	GRIA2;CREB1;DRD1;GRIA4
Pathways in cancer	16/325	0.008053713159505085	0.4343252453875957	0	0	1.9692307692307691	9.494886462719963	RB1;ITGB1;TCF7L2;FZD3;FZD5;HHIP;LEF1;CBLB;LAMC1;HIF1A;GLI3;KITLG;PIK3CA;FGF19;COL4A6;CTNNB1
Transmission across chemical synapses	11/190	0.008476604918739727	0.4413680492171375	0	0	2.31578947368421	11.047346947308263	GABRA2;GRIA2;CHRNB3;CREB1;GNG2;CACNA1A;SLC6A1;SLC18A2;GNAI1;NCALD;GRIA4
Bacterial invasion of epithelial cells	6/71	0.008618199165128973	0.4337826913114916	0	0	3.380281690140845	16.069450579234264	ITGB1;PIK3CA;GAB1;CTNNB1;CBLB;DNM1L
Apoptotic execution  phase	5/52	0.009471810530852916	0.46136883553509367	0	0	3.8461538461538463	17.920904631222058	TJP1;H1F0;SATB1;CTNNB1;DNM1L
Signaling events mediated by PTP1B	5/52	0.009471810530852916	0.446951059424622	0	0	3.8461538461538463	17.920904631222058	FER;PIK3CA;IRS1;SPRY2;PRLR
Signaling events mediated by stem cell factor receptor (c-Kit)	5/52	0.009471810530852916	0.4334070879269062	0	0	3.8461538461538463	17.920904631222058	FER;KITLG;PIK3CA;GRB10;GAB1
Human cytomegalovirus and MAP kinase pathways	3/18	0.009582224106397506	0.4255634823723598	0	0	6.666666666666666	30.985637016835305	RB1;CREB1;PIK3CA
Thrombin signaling through protease-activated receptors	5/53	0.01024902420142917	0.4421721869759442	0	0	3.7735849056603774	17.285180293547484	GNG2;PIK3CA;MAP3K7;GNAI1;F2RL2
Signaling by Hippo	3/20	0.012902143644594305	0.5411732473149278	0	0	5.999999999999999	26.10217084452193	MOB1B;TJP1;LATS2
ALK in cardiac myocytes	4/37	0.013278626831915668	0.5419115274646664	0	0	4.324324324324325	18.687998017259645	ATF2;BMPR2;CTNNB1;MAP3K7
Integration of energy metabolism	8/125	0.013327245294946983	0.5295826419834196	0	0	2.56	11.053938740966716	TCF7L2;GNG2;PRKAR1A;CACNA1A;CTNNB1;PAX6;ISL1;GNAI1
PI3K cascade	5/57	0.013793849088617314	0.5340695416362088	0	0	3.508771929824561	15.029938611919315	CREB1;PIK3CA;FGF19;GAB1;FRS2
SHP2 signaling	5/57	0.013793849088617314	0.5207178030953036	0	0	3.508771929824561	15.029938611919315	PIK3CA;IRS1;GAB1;FRS2;GNAI1
Integrated breast cancer pathway	9/152	0.014362570809804716	0.5289629737269542	0	0	2.3684210526315788	10.049517723867249	RB1;FER;BMPR2;CREB1;IRS1;NCOA3;MYCBP2;CTNNB1;FILIP1
BDNF signaling pathway	13/261	0.014623567277574467	0.5257520616461296	0	0	1.9923371647509576	8.417865304163042	DDX17;PNISR;TFAP2B;SEMA3A;IGF2;ANK3;FNDC3A;RORB;DKK1;CDH11;RBMS1;KCNK1;FBN1
Nicotine activity on dopaminergic neurons	3/21	0.014777987746011578	0.5189479417785461	0	0	5.7142857142857135	24.083522970404665	GNG2;GNAI1;SLC18A2
Signaling by FGFR in disease	8/128	0.015196841126295138	0.5215279568342196	0	0	2.5	10.466669233415214	CREB1;PIK3CA;PRKAR1A;FGF19;GAB1;SPRY2;FRS2;IL17RD
Signal transduction	37/1020	0.015229187092316429	0.5110238335421735	0	0	1.4509803921568627	6.0716876505927235	ITGB1;BMPR2;CALCB;IRS1;LPAR4;LAMC1;DTX4;HIF1A;GNAI1;GRM3;FGD4;GNG2;CYSLTR2;CALCR;HEY1;GRB10;DRD1;E2F5;FZD3;LHCGR;OPN3;FZD5;GAB1;ADAM10;FRS2;IL17RD;MOB1B;KITLG;FER;LATS2;CREB1;AGO3;FGF19;CTNNB1;COL6A6;F2RL2;FBN1
CHL1 interactions	2/8	0.01580491452517871	0.5188134985439098	0	0	10.0	41.47434341416576	ITGB1;CNTN6
E-cadherin nascent AJ-like junctions pathway	4/39	0.015905781183770465	0.5110155231381575	0	0	4.102564102564102	16.989015956420822	TJP1;PIK3CA;CTNND1;CTNNB1
Fibroblast growth factor receptor pathway	7/105	0.016319228364725734	0.5133757256403304	0	0	2.6666666666666665	10.974429899032433	CREB1;PIK3CA;FGF19;GAB1;SPRY2;CBLB;FRS2
SMAD2/3 nuclear pathway	6/82	0.016783871259473622	0.5172172571796974	0	0	2.9268292682926824	11.962937261822507	TGIF1;ATF2;NCOA2;CREB1;LAMC1;E2F5
TGF-beta signaling pathway	10/185	0.01824388577094862	0.5509653502826484	0	0	2.1621621621621623	8.657135743431049	ITGB1;TGIF1;ATF2;ZEB2;BAMBI;LEF1;SMAD9;CTNNB1;E2F5;MAP3K7
BAD phosphorylation mediated by IGF1R signaling	3/23	0.01896828932905573	0.5616101350367481	0	0	5.217391304347825	20.686887009392155	PIK3CA;IRS1;PRKAR1A
CREB transcription factor and its extracellular signals	3/23	0.01896828932905573	0.5508099401321952	0	0	5.217391304347825	20.686887009392155	CREB1;PIK3CA;PRKAR1A
Signaling by insulin receptor	7/109	0.019645167408776597	0.5597019393821258	0	0	2.5688073394495414	10.095217368867251	PIK3CA;IRS1;FGF19;PDE3B;GRB10;GAB1;FRS2
Collagen biosynthesis and modifying enzymes	5/64	0.02181970122725916	0.6101434972807653	0	0	3.125	11.95294372275165	COL25A1;COL11A1;COL4A6;COL6A6;TLL1
Androgen receptor signaling, proteolysis, and transcription regulation	6/88	0.0229589564722733	0.6303277140569579	0	0	2.727272727272727	10.292855886484162	RB1;SMARCE1;NCOA2;CREB1;NCOA3;CTNNB1
Heart development	4/44	0.02382609847412197	0.6424537267129317	0	0	3.6363636363636362	13.58899536203803	BMPR2;HEY1;CTNNB1;ISL1
Prostate cancer	6/89	0.024118332393649237	0.6389242441124623	0	0	2.696629213483146	10.044358779564119	RB1;TCF7L2;CREB1;PIK3CA;LEF1;CTNNB1
Beta-1 integrin cell surface interactions	5/66	0.02457069252754745	0.6396852709758043	0	0	3.0303030303030303	11.230911839233022	ITGB1;COL11A1;COL4A6;LAMC1;FBN1
Thyroid-stimulating hormone signaling pathway	5/66	0.02457069252754745	0.6288431477389262	0	0	3.0303030303030303	11.230911839233022	RB1;CREB1;GNG2;PIK3CA;GNAI1
Calcitonin-like ligand receptors	2/10	0.02457569018526242	0.6184882029957709	0	0	8.0	29.64798022792225	CALCB;CALCR
RhoA signaling pathway	4/45	0.02564991223851159	0.6349404504943033	0	0	3.5555555555555554	13.024764902655056	ITGB1;ATF2;PIP5K1B;F2RL2
Fibroblast growth factor 1	3/26	0.026359322007969647	0.6419770360005511	0	0	4.615384615384615	16.781230569993895	BAMBI;IGF2;S1PR3
YAP1- and WWTR1 (TAZ)-stimulated gene expression	3/26	0.026359322007969647	0.6317869243180027	0	0	4.615384615384615	16.781230569993895	NCOA2;CHD9;NCOA3
Prolactin regulation of apoptosis	7/118	0.028799815326509964	0.6794956428598444	0	0	2.3728813559322033	8.417526823370604	SMARCE1;MYB;IGF2;ANK3;FNDC3A;N4BP2L2;PCMTD1
BAD phosphorylation regulation	3/27	0.029117852235481113	0.6764301057780997	0	0	4.444444444444444	15.717350284548534	KITLG;PIK3CA;PRKAR1A
Control of gene expression by vitamin D receptor	3/27	0.029117852235481113	0.6661811647814618	0	0	4.444444444444444	15.717350284548534	SMARCE1;NCOA2;NCOA3
RORA activates circadian expression	3/27	0.029117852235481113	0.656238162322037	0	0	4.444444444444444	15.717350284548534	NCOA2;CHD9;NCOA3
Extracellular matrix organization	6/93	0.02914569343965597	0.64720583961589	0	0	2.5806451612903225	9.123737071017121	MMP16;COL25A1;COL11A1;COL4A6;COL6A6;TLL1
ALK2 pathway	2/11	0.02954667996708659	0.6466012572507356	0	0	7.2727272727272725	25.612973778194785	BMPR2;SMAD9
Apoptotic cleavage of cell adhesion  proteins	2/11	0.02954667996708659	0.637364096432868	0	0	7.2727272727272725	25.612973778194785	TJP1;CTNNB1
CDC42 signaling events	5/70	0.03071766872573008	0.6532912644486256	0	0	2.8571428571428568	9.951192175476	ATF2;PIK3CA;CTNNB1;PAX6;F2RL2
Presenilin action in Notch and Wnt signaling	4/48	0.03161375502500175	0.6630106956632312	0	0	3.333333333333333	11.513876558324146	ADAM10;CTNNB1;MAP3K7;DKK1
Multi-step regulation of transcription by PITX2	3/28	0.03202293203002463	0.6623921556895506	0	0	4.285714285714286	14.748441458133852	LEF1;CTNNB1;DKK1
Notch signaling pathway	7/121	0.03240084680689822	0.6611524145731934	0	0	2.3140495867768593	7.936196708618218	HEY1;CNTN6;ADAM10;CFLAR;DTX4;HIF1A;RAB11A
Angiopoietin receptor Tie2-mediated signaling	4/49	0.0337674247955063	0.6798508192161935	0	0	3.265306122448979	11.063701892761872	ITGB1;ANGPT4;ELF1;PIK3CA
Axon guidance	14/325	0.03484119498409191	0.6922395319207735	0	0	1.723076923076923	5.784291396605421	EPHA5;ITGB1;NFAT5;EPHA6;CNTN6;SEMA3A;ANK3;LAMC1;GNAI1;EFNB3;CREB1;SCN7A;COL6A6;SRGAP1
Parkin role in the ubiquitin-proteasomal pathway	2/12	0.03487854042134841	0.6839817667043648	0	0	6.666666666666666	22.372556843567576	SNCAIP;SNCA
IGF1 pathway	3/29	0.035073626746766035	0.678989440866881	0	0	4.137931034482758	13.863334368288841	PIK3CA;IRS1;GRB10
Thyroid cancer	3/29	0.035073626746766035	0.6703946378179331	0	0	4.137931034482758	13.863334368288841	TCF7L2;LEF1;CTNNB1
Myc repressed pathway	5/73	0.03590832173141458	0.6777695726804502	0	0	2.73972602739726	9.114482759579785	ITGB1;SFRP1;CREB1;CFLAR;DKK1
Type 2 diabetes mellitus	4/50	0.036004517553649654	0.6711953272347034	0	0	3.1999999999999997	10.637154754552185	PIK3CA;IRS1;IRS4;CACNA1A
Interleukin-4 regulation of apoptosis	12/267	0.036947056041576255	0.6803665197900018	0	0	1.797752808988764	5.929472914829088	CYSLTR2;LRRN3;SATB1;DENND4A;PCDH7;FAT1;RBMS1;LIFR;ELL2;POU4F1;GNAI1;FBN1
G alpha (s) signaling events	7/125	0.03765326408972758	0.6850172141625138	0	0	2.2399999999999998	7.345711817659683	LHCGR;CALCB;CALCR;GNG2;PDE3B;DRD1;GNAI1
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) biosynthesis	3/30	0.038268755933891604	0.68792644595448	0	0	4.0	13.052485950718438	NDST3;GPC3;GPC4
Glucose-dependent insulinotropic polypeptide (GIP) biosynthesis, secretion, and inactivation	2/13	0.040550197611673826	0.7203623340426761	0	0	6.153846153846154	19.724397693220933	PAX6;ISL1
Melanocyte development and pigmentation pathway	2/13	0.040550197611673826	0.7119860278328776	0	0	6.153846153846154	19.724397693220933	KITLG;CREB1
Organic anion transporters	2/13	0.040550197611673826	0.7038022803865227	0	0	6.153846153846154	19.724397693220933	SLC17A6;SLC17A8
Signal attenuation	2/13	0.040550197611673826	0.6958045272003122	0	0	6.153846153846154	19.724397693220933	IRS1;GRB10
Endometrial cancer	4/52	0.040729689807035306	0.6910318158272283	0	0	3.076923076923077	9.848609148264439	TCF7L2;PIK3CA;LEF1;CTNNB1
Interleukin-2 receptor beta chain in T cell activation	4/52	0.040729689807035306	0.683353684540259	0	0	3.076923076923077	9.848609148264439	RB1;PIK3CA;IRS1;CFLAR
Alpha-6 beta-4 integrin signaling pathway	3/31	0.04160691113161275	0.6904003935025852	0	0	3.8709677419354835	12.307699325969082	IRS1;GAB1;LAMC1
Serotonin HTR1 group and FOS pathway	3/32	0.045086472796717056	0.740006238293943	0	0	3.75	11.62189880794663	CREB1;PIK3CA;GNAI1
Signaling by SCF-KIT	5/78	0.045694746631016706	0.7419254560519918	0	0	2.564102564102564	7.912235746305283	FER;KITLG;CREB1;PIK3CA;GRB10
Nuclear beta-catenin signaling and target gene transcription regulation	5/80	0.05001216613714395	0.8033869241179508	0	0	2.5	7.488722451023223	NCOA2;TCF7L2;LEF1;CTNNB1;DKK1
BMP signaling pathway in stem cells	2/15	0.05283270093282616	0.8397618779849211	0	0	5.333333333333333	15.683333035361262	BMPR2;SMAD9
Eicosanoid ligand-binding G-protein coupled receptors	2/15	0.05283270093282616	0.8310143584225781	0	0	5.333333333333333	15.683333035361262	CYSLTR2;PTGER3
Repression of pain sensation by the transcriptional regulator DREAM	2/15	0.05283270093282616	0.8224472000883247	0	0	5.333333333333333	15.683333035361262	CREB1;PRKAR1A
Mechanism of gene regulation by peroxisome proliferators via PPAR-alpha	4/57	0.05400611450011817	0.8321350295426371	0	0	2.807017543859649	8.192724231142156	RB1;PIK3CA;PRKAR1A;FAT1
EGF receptor (ErbB1) signaling pathway	3/35	0.056354567885378765	0.8595494697668883	0	0	3.4285714285714284	9.860886785287258	PIK3CA;GAB1;GNAI1
Interleukin-2/PI3K pathway	3/35	0.056354567885378765	0.8509539750692194	0	0	3.4285714285714284	9.860886785287258	PIK3CA;MYB;EIF3A
ECM-receptor interaction	5/84	0.05934200894672073	0.8871924109856268	0	0	2.3809523809523805	6.724851928199624	ITGB1;COL11A1;COL4A6;COL6A6;LAMC1
Small cell lung cancer	5/84	0.05934200894672073	0.8784944461720423	0	0	2.3809523809523805	6.724851928199624	ITGB1;RB1;PIK3CA;COL4A6;LAMC1
B cell survival pathway	2/16	0.05940541077305161	0.8708948569641546	0	0	5.0	14.116849831533036	ITGB1;PIK3CA
Cell-extracellular matrix interactions	2/16	0.05940541077305161	0.8625208679548838	0	0	5.0	14.116849831533036	ITGB1;PARVA
GluR2-containing AMPA receptor trafficking	2/16	0.05940541077305161	0.8543063834981707	0	0	5.0	14.116849831533036	GRIA2;GRIA4
Hypoxia-inducible factor in the cardivascular system	2/16	0.05940541077305161	0.8462468893142256	0	0	5.0	14.116849831533036	CREB1;HIF1A
LPA4-mediated signaling events	2/16	0.05940541077305161	0.8383380398813824	0	0	5.0	14.116849831533036	CREB1;LPAR4
Sonic Hedgehog (Shh) pathway	2/16	0.05940541077305161	0.8305756506232215	0	0	5.0	14.116849831533036	PRKAR1A;GLI3
Signaling by EGFR in cancer	6/111	0.060018518221585736	0.8314491973816005	0	0	2.1621621621621623	6.082382978058848	CREB1;PIK3CA;PRKAR1A;GAB1;ADAM10;SPRY2
PI3K/PLC/TRK pathway	3/36	0.06037988610364689	0.8288511637864255	0	0	3.333333333333333	9.356997470103483	CREB1;PIK3CA;GAB1
TGF-beta regulation of skeletal system development	5/85	0.0618191895456952	0.8409637496756734	0	0	2.352941176470588	6.5495092994558615	BMPR2;ID4;SMAD9;E2F5;GDF6
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha)	6/112	0.062146090059919806	0.8378624642007045	0	0	2.142857142857143	5.9534300878912125	MED23;NCOA2;MED13;CHD9;NCOA3;MED4
Neurotrophic factor-mediated Trk receptor signaling	4/60	0.06296617067027598	0.8414063514346612	0	0	2.6666666666666665	7.373753787467152	RIT2;PIK3CA;GAB1;FRS2
Activation of NMDA receptor upon glutamate binding and postsynaptic events	3/37	0.06453588403923348	0.8548174113968645	0	0	3.2432432432432434	8.888217950878486	GRIA2;CREB1;GRIA4
PI3K/AKT activation	3/37	0.06453588403923348	0.8473842165151526	0	0	3.2432432432432434	8.888217950878486	CREB1;PIK3CA;IRS1
Wnt signaling pathway	10/231	0.06568264665663902	0.8550068659614216	0	0	1.7316017316017314	4.715013884703011	NFAT5;TCF7L2;SFRP1;FZD3;FZD5;RYK;LEF1;CTNNB1;DKK1;MAP3K7
Androgen receptor proteolysis and transcription regulation	4/61	0.06611592163711043	0.8532909544618525	0	0	2.622950819672131	7.124841151897977	TGIF1;NCOA2;LATS2;CTNNB1
Unblocking of NMDA receptor, glutamate binding and activation	2/17	0.0662415915707929	0.8476678243381126	0	0	4.705882352941176	12.773867020503221	GRIA2;GRIA4
BMAL1-CLOCK/NPAS2 activates circadian expression	3/38	0.06881998761828545	0.8732620277614372	0	0	3.157894736842105	8.451350711138838	NCOA2;CHD9;NCOA3
Signaling of hepatocyte growth factor receptor	3/38	0.06881998761828545	0.8659848441967586	0	0	3.157894736842105	8.451350711138838	ITGB1;PIK3CA;GAB1
Trefoil factor initiation of mucosal healing	3/38	0.06881998761828545	0.8588279446579424	0	0	3.157894736842105	8.451350711138838	ITGB1;PIK3CA;CTNNB1
Colorectal cancer	4/62	0.06934618550712146	0.858301148489782	0	0	2.5806451612903225	6.886823579964537	TCF7L2;PIK3CA;LEF1;CTNNB1
FAS pathway and stress induction of heat shock protein regulation	3/39	0.07322950908508677	0.8989964123453742	0	0	3.076923076923077	8.04355941437563	RB1;CFLAR;MAP3K7
GAB1 signalosome	3/39	0.07322950908508677	0.8917464412780728	0	0	3.076923076923077	8.04355941437563	CREB1;PIK3CA;GAB1
PKA activation in glucagon signaling	2/18	0.07332402120449992	0.885754176150359	0	0	4.444444444444444	11.612742279715478	CREB1;PRKAR1A
Sodium/chloride-dependent neurotransmitter transporters	2/18	0.07332402120449992	0.8787243811015467	0	0	4.444444444444444	11.612742279715478	SLC6A1;SLC18A2
Tie2 signaling	2/18	0.07332402120449992	0.8718052914865739	0	0	4.444444444444444	11.612742279715478	ANGPT4;PIK3CA
Leukocyte transendothelial migration	6/117	0.0734450920200029	0.8664225699234718	0	0	2.051282051282051	5.356342972900848	ITGB1;PIK3CA;CTNND1;CTNNB1;CLDN2;GNAI1
MAPK cascade role in angiogenesis	4/64	0.07604536088191723	0.8901433715635272	0	0	2.5	6.441063157581755	ATF2;SEMA3A;FRS2;MAP3K7
Validated nuclear estrogen receptor alpha network	4/64	0.07604536088191723	0.8832961148591923	0	0	2.5	6.441063157581755	DDX17;NCOA2;NCOA3;POU4F1
Negative regulation of FGFR signaling	3/40	0.07776165816733924	0.8963366704784904	0	0	2.9999999999999996	7.6623203846665575	FGF19;SPRY2;FRS2
LPA receptor mediated events	4/65	0.079512678248973	0.9095768496662819	0	0	2.4615384615384617	6.232218572816643	GNG2;GAB1;LPAR4;GNAI1
IGF-1 receptor and longevity	2/19	0.08063617099611983	0.915493369955947	0	0	4.2105263157894735	10.601296667256518	PIK3CA;IRS1
PTEN-dependent cell cycle arrest and apoptosis	2/19	0.08063617099611983	0.9086613298816489	0	0	4.2105263157894735	10.601296667256518	ITGB1;PIK3CA
Signaling by constitutively active EGFR	2/19	0.08063617099611983	0.9019305052158589	0	0	4.2105263157894735	10.601296667256518	PIK3CA;GAB1
Small ligand GPCRs	2/19	0.08063617099611983	0.8952986632657423	0	0	4.2105263157894735	10.601296667256518	PTGER3;S1PR3
ERBB1 internalization pathway	3/41	0.08241355278955437	0.9083537570235554	0	0	2.9268292682926824	7.305381599970589	PIK3CA;SPRY2;CBLB
Plasma membrane estrogen receptor signaling	3/41	0.08241355278955437	0.9017714834219355	0	0	2.9268292682926824	7.305381599970589	GNG2;PIK3CA;GNAI1
Antigen-activated B-cell receptor generation of second messengers	9/211	0.08380760694450949	0.9104279603324412	0	0	1.7061611374407584	4.229968437076357	ATF2;NFAT5;IBTK;CREB1;PIK3CA;GAB1;CBLB;PIP5K1B;MAP3K7
L1CAM interactions	5/94	0.08668636111653329	0.9349743234711805	0	0	2.127659574468085	5.203103657017745	ITGB1;CNTN6;SCN7A;LAMC1;ANK3
Aldosterone-regulated sodium reabsorption	3/42	0.08718222910547488	0.93365365921466	0	0	2.8571428571428568	6.970727895708977	PIK3CA;IRS1;IRS4
Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP)	3/42	0.08718222910547488	0.9270786334455428	0	0	2.8571428571428568	6.970727895708977	ITGB1;PIK3CA;GAB1
Estrogen receptor signaling pathway	2/20	0.08816218183787267	0.9309433187076066	0	0	4.0	9.714308741076266	CREB1;PIK3CA
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) degradation	2/20	0.08816218183787267	0.9244784345499149	0	0	4.0	9.714308741076266	GPC3;GPC4
Peroxisomal lipid metabolism	2/20	0.08816218183787267	0.9181027212081913	0	0	4.0	9.714308741076266	IDH1;FAR2
Insulin signaling pathway	11/277	0.08913717641025129	0.9218981943799962	0	0	1.5884476534296028	3.8401973525664133	CREB1;PIK3CA;PRKAR1A;IRS1;PDE3B;GAB1;IRS4;GRB10;CBLB;MAP3K7;F2RL2
Class B GPCRs (secretin family receptors)	5/95	0.08973008930567587	0.9217172438882353	0	0	2.1052631578947367	5.075682362950664	FZD3;CALCB;CALCR;GNG2;FZD5
Beta-3 integrin cell surface interactions	3/43	0.0920646511043347	0.939308264645577	0	0	2.7906976744186043	6.656551309777228	COL4A6;LAMC1;FBN1
Growth hormone receptor signaling	3/43	0.0920646511043347	0.9330041823325195	0	0	2.7906976744186043	6.656551309777228	PIK3CA;IRS1;PRLR
GPCR ligand binding	15/410	0.09219228574877912	0.9280690098710431	0	0	1.4634146341463412	3.4886031520805063	FZD3;LHCGR;CALCB;OPN3;FZD5;PTGER3;TRH;LPAR4;GRM3;CYSLTR2;CALCR;GNG2;S1PR3;DRD1;F2RL2
IGF1 signaling pathway	2/21	0.09588684119947874	0.9588684119947873	0	0	3.8095238095238093	8.931758172484527	PIK3CA;IRS1
G-protein-mediated events	3/44	0.09705771960273352	0.9641918197376815	0	0	2.727272727272727	6.361225718177528	CREB1;PRKAR1A;GNAI1
PI3K events in ERBB2 signaling	3/44	0.09705771960273352	0.9578899124191347	0	0	2.727272727272727	6.361225718177528	CREB1;PIK3CA;GAB1
Signaling events mediated by VEGFR1 and VEGFR2	4/70	0.09798976602376523	0.9608087447784773	0	0	2.2857142857142856	5.309467963642306	PIK3CA;GRB10;GAB1;CTNNB1
Rac1 cell motility signaling pathway	4/71	0.10190606046315834	0.9927622664475424	0	0	2.2535211267605635	5.14637490908864	ATF2;PIK3CA;CTNNB1;PIP5K1B
Integrin-linked kinase signaling	3/45	0.10215828081331627	0.988839769410946	0	0	2.6666666666666665	6.0832850553957645	CREB1;CTNNB1;PARVA
Signaling by FGFR mutants	3/45	0.10215828081331627	0.9825414269306214	0	0	2.6666666666666665	6.0832850553957645	PIK3CA;GAB1;FRS2
Alpha-6 beta-1 and alpha-6 beta-4 integrin signaling	3/46	0.10736313441562158	1.0	0	0	2.6086956521739126	5.821404549935052	ITGB1;PIK3CA;LAMC1
Signaling by NOTCH1	4/73	0.10995046855934236	1.0	0	0	2.191780821917808	4.838849973529832	HEY1;ADAM10;DTX4;HIF1A
Angiogenesis	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	PIK3CA;HIF1A
Collagen binding in corneal epithelia mediated by Erk and PI-3 Kinase	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	ITGB1;PIK3CA
Eicosanoid metabolism	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	CYSLTR2;PTGER3
Nitrogen metabolism	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	CTH;CA14
Signaling by bone morphogenetic protein (BMP)	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	BMPR2;SMAD9
Signaling events mediated by the hedgehog family	2/23	0.11187435504137663	1.0	0	0	3.4782608695652173	7.618709103989623	PIK3CA;HHIP
Actions of nitric oxide in the heart	3/47	0.11266904115423244	1.0	0	0	2.553191489361702	5.57438450312141	PIK3CA;PRKAR1A;PDE3B
Integrins in angiogenesis	4/74	0.11407613801901988	1.0	0	0	2.1621621621621623	4.693814434937615	PIK3CA;IRS1;COL11A1;COL4A6
Wnt/calcium/cyclic GMP pathway	4/74	0.11407613801901988	1.0	0	0	2.1621621621621623	4.693814434937615	NFAT5;FZD3;FZD5;PLCH1
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	4/75	0.11826909586753341	1.0	0	0	2.1333333333333333	4.5542245917778965	ITGB1;TCF7L2;LEF1;CTNNB1
Prolactin activation of MAPK signaling	4/75	0.11826909586753341	1.0	0	0	2.1333333333333333	4.5542245917778965	ITGB1;PIK3CA;IRS1;PRLR
CREB phosphorylation through the activation of adenylate cyclase	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	CREB1
Dopamine receptors	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	DRD1
FOSB gene expression and drug abuse	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	GRIA2
Insulin receptor substrate (IRS) activation	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	IRS1
Leukotriene receptors	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	CYSLTR2
N-glycan trimming and elongation in the cis-Golgi	1/5	0.11891526936765551	1.0	0	0	8.0	17.03475249279432	MAN1A1
Interleukin-4 signaling pathway	5/104	0.11952734733413012	1.0	0	0	1.9230769230769231	4.085019395784471	ATF2;PIK3CA;IRS1;MYB;IRS4
Plexin D1 signaling	2/24	0.12010982001247623	1.0	0	0	3.333333333333333	7.064495959797489	ITGB1;PIP5K1B
Ras-independent pathway in NK cell-mediated cytotoxicity	2/24	0.12010982001247623	1.0	0	0	3.333333333333333	7.064495959797489	ITGB1;PIK3CA
Signal transduction of S1P receptor	2/24	0.12010982001247623	1.0	0	0	3.333333333333333	7.064495959797489	S1PR3;GNAI1
Tumor suppressor Arf inhibits ribosomal biogenesis	2/24	0.12010982001247623	1.0	0	0	3.333333333333333	7.064495959797489	RB1;PIK3CA
Amino acid and oligopeptide SLC transporters	3/49	0.12357090514220292	1.0	0	0	2.4489795918367343	5.120669772142008	SLC17A6;SLC17A8;SLC38A4
Arf6 integrin-mediated signaling pathway	3/49	0.12357090514220292	1.0	0	0	2.4489795918367343	5.120669772142008	ITGB1;CTNND1;CTNNB1
FSH regulation of apoptosis	10/263	0.12499483608691939	1.0	0	0	1.520912547528517	3.1627115647723443	LHCGR;RAB31;PRKAR1A;IDH1;CTNND1;IGF2;ID4;CFLAR;DKK1;MAP3K7
NGF signaling via TRKA from the plasma membrane	6/136	0.12618182871538566	1.0	0	0	1.7647058823529411	3.652996459825553	CREB1;RIT2;PIK3CA;IRS1;PRKAR1A;FRS2
ERBB1 downstream pathway	5/106	0.1267114019022413	1.0	0	0	1.8867924528301887	3.8978173667325606	ATF2;CREB1;PIK3CA;GAB1;F2RL2
Mitochondrial pathway of apoptosis: caspases	4/77	0.12685161688191973	1.0	0	0	2.0779220779220777	4.290363109838066	RB1;CAPN6;MAP3K7;GSPT2
Jak-STAT signaling pathway	8/199	0.12705133365575216	1.0	0	0	1.608040201005025	3.3176507693304553	PTPRD;PIK3CA;PTPRZ1;SPRY2;CBLB;LIFR;PRLR;PTPN14
Ck1/Cdk5 regulation by type 1 glutamate receptors	2/25	0.12848911332067864	1.0	0	0	3.1999999999999997	6.566115518322446	PRKAR1A;DRD1
Ligand-gated ion channel transport	2/25	0.12848911332067864	1.0	0	0	3.1999999999999997	6.566115518322446	GABRA2;GLRA2
Aquaporin-mediated transport	3/50	0.12916025190606503	1.0	0	0	2.4	4.912083318606716	GNG2;PRKAR1A;RAB11A
Glutathione metabolism	3/51	0.13483744322316818	1.0	0	0	2.352941176470588	4.714553765545066	GSTA4;IDH1;GPX7
Type I interferon (interferon-alpha/beta) pathway	3/51	0.13483744322316818	1.0	0	0	2.352941176470588	4.714553765545066	PTPRD;PTPRZ1;PTPN14
Signaling events mediated by hepatocyte growth factor receptor (c-Met)	4/79	0.13568722199833994	1.0	0	0	2.0253164556962022	4.045372921890401	PIK3CA;GAB1;CTNNB1;F2RL2
ALK1 pathway	2/26	0.1369999344737361	1.0	0	0	3.076923076923077	6.116230250609304	BMPR2;SMAD9
Estrogen receptor transcription factor targets	2/26	0.1369999344737361	1.0	0	0	3.076923076923077	6.116230250609304	NCOA2;NCOA3
Interaction between L1-type proteins and ankyrins	2/26	0.1369999344737361	1.0	0	0	3.076923076923077	6.116230250609304	SCN7A;ANK3
Segmentation clock	2/26	0.1369999344737361	1.0	0	0	3.076923076923077	6.116230250609304	CTNNB1;DKK1
Steroid biosynthesis	2/26	0.1369999344737361	1.0	0	0	3.076923076923077	6.116230250609304	SQLE;HSD17B2
TGF-beta signaling in development	2/26	0.1369999344737361	1.0	0	0	3.076923076923077	6.116230250609304	BMPR2;SMAD9
Tetrasaccharide linker sequence formation in glycosaminoglycan biosynthesis	2/26	0.1369999344737361	1.0	0	0	3.076923076923077	6.116230250609304	GPC3;GPC4
Opioid signaling	4/80	0.14019643720239597	1.0	0	0	2.0	3.9294214339112856	CREB1;GNG2;PRKAR1A;GNAI1
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) metabolism	3/52	0.14059914501552925	1.0	0	0	2.3076923076923075	4.527328570603137	NDST3;GPC3;GPC4
ADP signalling through P2Y purinoceptor 1	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	GNG2
G beta-gamma signaling through PI3K gamma	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	GNG2
Klotho-mediated ligand binding	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	FGF19
Multi-drug resistance factors	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	ABCB11
PIK3C1/B pathway	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	PDE3B
Small interfering RNA (siRNA) biogenesis	1/6	0.14094786294456849	1.0	0	0	6.666666666666666	13.062434822233206	AGO3
Fatty acid, triacylglycerol, and ketone body metabolism	7/173	0.1437452070018003	1.0	0	0	1.6184971098265895	3.1394197912594404	MED23;NCOA2;MED13;CHD9;NCOA3;MED4;AGPAT4
MAP kinase signaling pathway	4/81	0.14476468418008995	1.0	0	0	1.9753086419753085	3.817571797652061	ATF2;CREB1;RAPGEF2;MAP3K7
Epidermal growth factor receptor (EGFR) pathway	5/111	0.14550403989770552	1.0	0	0	1.8018018018018016	3.47306563447942	CREB1;PIK3CA;GAB1;SPRY2;CBLB
ADP signalling through P2Y purinoceptor 12	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	GNG2;GNAI1
ERK5 role in neuronal survival pathway	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	CREB1;PIK3CA
Mammalian calpain regulation of cell motility	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	ITGB1;PRKAR1A
VEGFR1 pathway	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	PIK3CA;HIF1A
eIF4E and p70 S6 kinase regulation	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	PIK3CA;IRS1
Androgen receptor regulation of biosynthesis and transcription	3/53	0.14644202157094957	1.0	0	0	2.2641509433962264	4.349718534458366	SMARCE1;NCOA2;APPBP2
GABA A and B receptor activation	3/53	0.14644202157094957	1.0	0	0	2.2641509433962264	4.349718534458366	GABRA2;GNG2;GNAI1
JNK/MAPK pathway	3/53	0.14644202157094957	1.0	0	0	2.2641509433962264	4.349718534458366	ATF2;GAB1;MAP3K7
PI3K pathway	3/53	0.14644202157094957	1.0	0	0	2.2641509433962264	4.349718534458366	PIK3CA;IRS1;IRS4
Phospholipase C-mediated cascade	3/54	0.15236274042928305	1.0	0	0	2.222222222222222	4.1810914466514895	CREB1;PRKAR1A;FGF19
mTOR signaling pathway	5/113	0.15333823216929846	1.0	0	0	1.7699115044247786	3.3187772207916013	PIK3CA;IRS1;RB1CC1;HIF1A;EIF3A
Apoptosis	9/242	0.15409546113463288	1.0	0	0	1.487603305785124	2.7820904000066613	TJP1;H1F0;PIK3CA;PRKAR1A;SATB1;IGF2;CTNNB1;CFLAR;DNM1L
G-protein activation	2/28	0.15436955442437558	1.0	0	0	2.8571428571428568	5.338302420588211	GNG2;GNAI1
TRAIL signaling pathway	2/28	0.15436955442437558	1.0	0	0	2.8571428571428568	5.338302420588211	PIK3CA;CFLAR
Fas signaling pathway	5/115	0.16134404267286037	1.0	0	0	1.7391304347826086	3.1725500572747882	RB1;NFAT5;PIK3CA;CFLAR;MAP3K7
CREB phosphorylation	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	CREB1
Endothelial NOS activation	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	ZDHHC21
Internal ribosome entry pathway	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	EIF3A
Phase I of biological oxidations: non-cytochrome P450 enzymes	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	ESD
Post-transcriptional silencing by small RNAs	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	AGO3
Telomerase RNA component gene hTERC transcriptional regulation	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	RB1
Wnt/LRP6 signaling	1/7	0.16243058031155067	1.0	0	0	5.7142857142857135	10.385740380401181	DKK1
Amine compound SLC transporters	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	SLC6A1;SLC18A2
Influence of Ras and Rho proteins on G1 to S transition	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	RB1;PIK3CA
Inhibition of insulin secretion by adrenaline/noradrenaline	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	GNG2;GNAI1
Reelin signaling pathway	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	ITGB1;PIK3CA
S1P/S1P3 pathway	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	S1PR3;GNAI1
C-Myb transcription factor network	4/85	0.16359856361460354	1.0	0	0	1.8823529411764706	3.4076981359319904	KITLG;MYB;LEF1;MAP3K7
Lipid and lipoprotein metabolism	16/489	0.16696513244471153	1.0	0	0	1.30879345603272	2.3427013838799815	CDS1;NCOA2;PCYT1B;ASAH2;CHD9;NCOA3;IDH1;MED4;ABCB11;AGPAT4;MED23;SQLE;MED13;PIK3CA;PIP5K1B;FAR2
Acute myeloid leukemia	3/57	0.1705587717216263	1.0	0	0	2.1052631578947367	3.723527030473866	TCF7L2;PIK3CA;LEF1
Activation of kainate receptors upon glutamate binding	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	GNG2;NCALD
Glutamate binding and activation of AMPA receptors and synaptic plasticity	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	GRIA2;GRIA4
Interferon-beta enhancer pathway	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	SMARCE1;ATF2
Interleukin-2/STAT5 pathway	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	ELF1;PIK3CA
Nectin adhesion pathway	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	PIK3CA;CTNNB1
Nuclear events mediated by MAP kinases	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	ATF2;CREB1
Ovarian infertility genes	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	LHCGR;PRLR
Retinoic acid receptor-mediated signaling	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	NCOA2;NCOA3
Signaling pathway from G-protein families	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	CREB1;PRKAR1A
TNFR1 signaling pathway	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	RB1;MAP3K7
Tumor necrosis factor (TNF) pathway	2/30	0.17213040735200277	1.0	0	0	2.6666666666666665	4.692007752438898	CFLAR;MAP3K7
Signaling by NOTCH	5/119	0.17784346282582597	1.0	0	0	1.680672268907563	2.90227149232865	AGO3;HEY1;ADAM10;DTX4;HIF1A
Activated NOTCH1 signaling in the nucleus	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	ADAM10;DTX4
Signal amplification	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	GNG2;GNAI1
Stathmin and breast cancer resistance to antimicrotubule agents	2/31	0.18113203111493761	1.0	0	0	2.5806451612903225	4.40910725152166	PRKAR1A;RB1CC1
ATF2 transcription factor network	3/59	0.18301812654553012	1.0	0	0	2.0338983050847457	3.453905245189201	RB1;ATF2;CREB1
RNA degradation	3/59	0.18301812654553012	1.0	0	0	2.0338983050847457	3.453905245189201	DDX6;DIS3;PAPOLA
Binding of RNA by insulin-like growth factor 2 mRNA binding proteins (IGF2BPs/IMPs/VICKZs)	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	IGF2
Cytoskeletal remodeling regulation and cell spreading by IPP complex components	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	PARVA
Degradation of cysteine and homocysteine	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	CTH
Gene expression regulation in early pancreatic precursor cells	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	PTF1A
Lysosphingolipid and lysophosphatidic acid (LPA) G-protein coupled receptors	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	S1PR3
NOD-like receptor (NLR) proteins	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	MAP3K7
Organic cation transport	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	SLC22A15
Support of platelet aggregation by Eph kinases and ephrins	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	ITGB1
Transport of nucleotide sugars	1/8	0.18337711757031785	1.0	0	0	5.0	8.481052474133024	SLC35D1
Ephrin receptor B forward pathway	3/60	0.18933665205922548	1.0	0	0	2.0	3.3284572412017854	EFNB3;PIK3CA;MAP3K7
Pancreatic beta-cell development regulation	2/32	0.1902017379712103	1.0	0	0	2.5	4.149174978285558	PAX6;PTF1A
Myometrial relaxation and contraction pathways	6/155	0.19279598910173565	1.0	0	0	1.5483870967741935	2.548835149062689	ATF2;CREB1;GNG2;PRKAR1A;CALD1;RYR3
Leptin signaling pathway	3/61	0.19571013951815233	1.0	0	0	1.9672131147540983	3.2087618250165857	CREB1;IRS1;PDE3B
Glucagon signaling in metabolic regulation	2/33	0.19933052198776197	1.0	0	0	2.4242424242424243	3.9097961637318743	GNG2;PRKAR1A
PIP biosynthesis at the plasma membrane	2/33	0.19933052198776197	1.0	0	0	2.4242424242424243	3.9097961637318743	PIK3CA;PIP5K1B
AKT phosphorylation of nuclear targets	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	CREB1
Alpha-4 beta-7 integrin signaling	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	ITGB1
Calcium/calmodulin-dependent protein kinase activation	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	CREB1
Gene expression regulation by hypoxia-inducible factor	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	HIF1A
Inactivation of Cdc42 and Rac	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	SRGAP1
Opsins	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	OPN3
PPAR-gamma coactivator role in obesity and thermogenesis	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	NCOA2
Polyadenylation of mRNA	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	PAPOLA
Prostanoid ligand receptors	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	PTGER3
Rapid glucocorticoid receptor pathway	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	GNG2
West Nile virus infection	1/9	0.20380083047636524	1.0	0	0	4.444444444444444	7.069387036640817	TIAL1
Neurotrophin signaling pathway	5/126	0.20813463115565656	1.0	0	0	1.5873015873015872	2.491381180151027	PIK3CA;IRS1;IRS4;GAB1;FRS2
Cysteine and methionine metabolism	2/34	0.20850978329059616	1.0	0	0	2.352941176470588	3.6888689802047985	CTH;TRDMT1
Ephrin receptor A forward pathway	2/34	0.20850978329059616	1.0	0	0	2.352941176470588	3.6888689802047985	EPHA5;EPHA6
MAPK/TRK pathway	2/34	0.20850978329059616	1.0	0	0	2.352941176470588	3.6888689802047985	CREB1;RIT2
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	4/96	0.21934791524686295	1.0	0	0	1.6666666666666665	2.5284935927439762	SLC22A15;SLC2A12;SLC6A1;SLC18A2
Activation of calcium-permeable kainate receptor	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	NCALD
Activation of the AP-1 family of transcription factors	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	ATF2
IRAK2-mediated activation of TAK1 complex	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	MAP3K7
Phospholipase C signaling pathway	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	PIK3CA
Neurotransmitter release cycle	2/36	0.22698728149273847	1.0	0	0	2.222222222222222	3.2952473149705526	SLC6A1;SLC18A2
Phospholipids as signaling intermediaries	2/36	0.22698728149273847	1.0	0	0	2.222222222222222	3.2952473149705526	PIK3CA;GNAI1
Signaling to ERKs	2/36	0.22698728149273847	1.0	0	0	2.222222222222222	3.2952473149705526	RIT2;FRS2
HIF-1 transcriptional activity in hypoxia	3/66	0.22829261173331122	1.0	0	0	1.8181818181818181	2.685685614666917	NCOA2;CREB1;HIF1A
Retinoblastoma protein regulation	3/66	0.22829261173331122	1.0	0	0	1.8181818181818181	2.685685614666917	RB1;ATF2;ELF1
Focal adhesion	8/233	0.2293475934933584	1.0	0	0	1.3733905579399142	2.0223403271687075	ITGB1;PIK3CA;COL11A1;COL4A6;CTNNB1;PARVA;COL6A6;LAMC1
G1 to S cell cycle control	3/67	0.23493078009641188	1.0	0	0	1.7910447761194028	2.594264527179215	RB1;CREB1;E2F5
Potassium channels	4/99	0.23536329754558818	1.0	0	0	1.6161616161616161	2.337979816697194	GNG2;KCND2;KCNH7;KCNK1
Tight junction	5/133	0.23995771281939338	1.0	0	0	1.5037593984962405	2.1463046131585695	TJP1;RRAS2;CTNNB1;CLDN2;GNAI1
Epithelial cell signaling in Helicobacter pylori infection	3/68	0.2416025942539262	1.0	0	0	1.7647058823529411	2.5066960150114252	TJP1;PTPRZ1;ADAM10
Attenuation of GPCR signaling	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	PRKAR1A
BTG family proteins and cell cycle regulation	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	RB1
Bone mineralization regulation	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	COL4A6
Cardiac protection against reactive oxygen species	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	GABRA2
Cystic fibrosis transmembrane conductance regulator (CFTR) and beta 2 adrenergic receptor (b2AR) pathway	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	PRKAR1A
E2F1 destruction pathway	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	RB1
Erythropoietin-mediated neuroprotection through NF-kB	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	HIF1A
Glypican-3 pathway	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	GPC3
Hormone ligand-binding G-protein coupled receptors	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	LHCGR
Integrin beta-4 pathway	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	LAMC1
Messenger RNA decay by 3' to 5' exoribonuclease	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	DIS3
Monocyte and its surface molecules	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	ITGB1
Norepinephrine neurotransmitter release cycle	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	SLC18A2
Notch receptor processing	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	ADAM10
Recycling of bile acids and salts	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	ABCB11
TGF-beta signaling in gastrointestinal stem cells	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	SMAD9
Vitamin C in the brain	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	COL4A6
Cyclin D-associated events in G1	2/38	0.24557301167059375	1.0	0	0	2.1052631578947367	2.956128370698781	RB1;E2F5
EGFR interaction with phospholipase C-gamma	2/38	0.24557301167059375	1.0	0	0	2.1052631578947367	2.956128370698781	CREB1;PRKAR1A
ERBB4 signaling events	2/38	0.24557301167059375	1.0	0	0	2.1052631578947367	2.956128370698781	PIK3CA;PRLR
Nuclear receptors	2/38	0.24557301167059375	1.0	0	0	2.1052631578947367	2.956128370698781	ESRRB;NR2F2
p38 alpha/beta MAPK downstream pathway	2/38	0.24557301167059375	1.0	0	0	2.1052631578947367	2.956128370698781	ATF2;CREB1
TGF-beta regulation of extracellular matrix	17/565	0.25045343418005284	1.0	0	0	1.2035398230088494	1.6662795428656731	RB1;DENND4A;CELF2;SEMA3A;NCOA3;NR2F2;ANK3;LAMC1;DKK1;SFRP1;EFNB3;BAMBI;CTH;ID4;HAS2;ADAMTS6;FBN1
Signaling by ERBB2	4/102	0.25164686509502815	1.0	0	0	1.5686274509803921	2.164280005079847	CREB1;PIK3CA;PRKAR1A;GAB1
Oncostatin M	10/311	0.25280389875972853	1.0	0	0	1.2861736334405143	1.768670346648623	H1F0;PTPRZ1;IRS1;HSD17B2;CDH11;GAB1;LIFR;DNM1L;HIF1A;PRLR
FRS2-mediated cascade	2/39	0.25488887753083794	1.0	0	0	2.051282051282051	2.8039540578253006	FGF19;FRS2
Long-term depression	3/70	0.2550357246055415	1.0	0	0	1.7142857142857142	2.342317109389694	GRIA2;CACNA1A;GNAI1
Renal cell carcinoma	3/70	0.2550357246055415	1.0	0	0	1.7142857142857142	2.342317109389694	PIK3CA;GAB1;HIF1A
Gastrin-CREB signaling pathway via PKC and MAPK	7/206	0.25773585549622413	1.0	0	0	1.3592233009708736	1.8428621827124072	CYSLTR2;CREB1;GNG2;PIK3CA;LPAR4;TRH;F2RL2
Melanoma	3/71	0.26179144524840503	1.0	0	0	1.6901408450704225	2.2651387651401085	RB1;PIK3CA;FGF19
BMP signaling and regulation	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	BMPR2
Dopamine neurotransmitter release cycle	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	SLC18A2
Facilitative sodium-independent glucose transporters	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	SLC2A12
GABA (A) receptor activation	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	GABRA2
Gamma-aminobutyric acid receptor life cycle	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	GABRA2
Inhibition of replication initiation of damaged DNA by RB1/E2F1	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	RB1
Nucleotide G-protein coupled receptors (GPCRs)	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	LPAR4
Opening of calcium channels triggered by depolarization of the presynaptic terminal	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	CACNA1A
Phospholipase C epsilon pathway	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	PRKAR1A
Rab GTPases mark targets in the endocytotic machinery	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	RAB11A
Reversible hydration of carbon dioxide	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	CA14
Tandem pore domain potassium channels	1/12	0.26206365162305645	1.0	0	0	3.333333333333333	4.463892865337529	KCNK1
Amoebiasis	4/105	0.2681573440683617	1.0	0	0	1.523809523809524	2.005609700597553	PIK3CA;COL11A1;COL4A6;LAMC1
Bioactive peptide-induced signaling pathway	2/41	0.2735343283108339	1.0	0	0	1.951219512195122	2.529420780778097	PIK3CA;GNAI1
Transcriptional activity of SMAD2/SMAD3-SMAD4 heterotrimer	2/41	0.2735343283108339	1.0	0	0	1.951219512195122	2.529420780778097	TGIF1;E2F5
Chronic myeloid leukemia	3/73	0.275367586439176	1.0	0	0	1.643835616438356	2.1199699658854088	RB1;PIK3CA;CBLB
Activation of DNA fragmentation factor	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	H1F0
Adenylate cyclase inhibitory pathway	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	GNAI1
Advanced glycosylation endproduct receptor signaling	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	CAPZA2
Angiotensin-converting enzyme 2 regulation of heart function	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	COL4A6
Death receptor signaling	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	CFLAR
FGFR4 ligand binding and activation	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	FGF19
Keap1-Nrf2 pathway	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	PIK3CA
Organic cation/anion/zwitterion transport	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	SLC22A15
PI3K class IB pathway	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	GNAI1
Platelet adhesion to exposed collagen	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	ITGB1
p27 phosphorylation regulation during cell cycle progression	1/13	0.28052310882224873	1.0	0	0	3.076923076923077	3.911074378522308	RB1
RANKL regulation of apoptosis and immune response	3/74	0.28218271785894006	1.0	0	0	1.6216216216216217	2.051676457611424	CALCR;ADAM10;SNCA
TWEAK signaling pathway	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	CTNNB1;MAP3K7
VEGF, hypoxia, and angiogenesis	2/42	0.2828519333369492	1.0	0	0	1.9047619047619047	2.4053937562173484	PIK3CA;HIF1A
Transmembrane transport of small molecules	13/432	0.2865237081270278	1.0	0	0	1.2037037037037035	1.5045501796136374	GABRA2;SLC35D1;SLC2A12;SLC6A1;RAB11A;GLRA2;SLC22A15;GNG2;PRKAR1A;SLC17A6;SLC17A8;SLC18A2;SLC38A4
Calcium signaling pathway	6/178	0.28690868886067566	1.0	0	0	1.348314606741573	1.6834938487080762	LHCGR;CYSLTR2;PTGER3;CACNA1A;DRD1;RYR3
Insulin secretion regulation by glucagon-like peptide-1	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	GNG2;PRKAR1A
Voltage-gated potassium channels	2/43	0.2921586298875362	1.0	0	0	1.8604651162790697	2.2892248766192735	KCND2;KCNH7
Interleukin-5 regulation of apoptosis	5/144	0.29227663758117584	1.0	0	0	1.3888888888888888	1.7084090780929468	CREB1;HEY1;HAS2;MAP3K7;HIF1A
SLC-mediated transmembrane transport	8/251	0.29264898034887604	1.0	0	0	1.2749003984063745	1.56657390591357	SLC22A15;SLC35D1;SLC2A12;SLC17A6;SLC17A8;SLC6A1;SLC18A2;SLC38A4
Glycosaminoglycan metabolism	4/110	0.29606967026845615	1.0	0	0	1.4545454545454544	1.77041524338222	NDST3;GPC3;HAS2;GPC4
Acetylcholine binding and downstream events	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	CHRNB3
Adhesion and diapedesis of lymphocytes	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	ITGB1
Hyaluronan metabolism	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	HAS2
Initiation of the second proteolytic cleavage of Notch receptor by receptor-ligand binding	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	ADAM10
Intronless pre-mRNA processing	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	PAPOLA
Platelet amyloid precursor protein pathway	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	COL4A6
S1P/S1P4 pathway	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	GNAI1
Sema3A-plexin repulsion signaling by inhibiting integrin adhesion	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	SEMA3A
Signaling by NOTCH2	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	ADAM10
T cell receptor/JNK pathway	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	MAP3K7
Viral messenger RNA biosynthesis	1/14	0.29852170306951037	1.0	0	0	2.8571428571428568	3.4540361191199316	GTF2F2
Gastrin pathway	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	ITGB1;CTNNB1
HNF3A pathway	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	NCOA3;NR2F2
Vasopressin-regulated water reabsorption	2/44	0.30144914903771564	1.0	0	0	1.8181818181818181	2.180279885359369	CREB1;RAB11A
G alpha (12/13) signaling events	3/77	0.30270573541973567	1.0	0	0	1.5584415584415583	1.8623284918379568	FGD4;GNG2;PIK3CA
Peroxisome	3/78	0.309564425132796	1.0	0	0	1.5384615384615385	1.8039831534931936	IDH1;PEX2;FAR2
Phosphatidylinositol signaling system	3/78	0.309564425132796	1.0	0	0	1.5384615384615385	1.8039831534931936	CDS1;PIK3CA;PIP5K1B
G alpha (z) signaling events	2/45	0.31071849114810757	1.0	0	0	1.7777777777777777	2.077987466447498	GNG2;GNAI1
Arf6 vesicle-mediated transport	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	RAB11A
Bile acid and bile salt biosynthesis via 7-alpha-hydroxycholesterol	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	ABCB11
Calcium signaling by HBx of hepatitis B virus	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	CREB1
Erythrocyte differentiation pathway	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	KITLG
Glycosphingolipid biosynthesis: ganglio series	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	ST6GALNAC3
Glycosylation of mammalian N-linked oligosaccarides	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	MAN1A1
Interleukin-17 signaling pathway	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	KITLG
Messenger RNA decay by 5' to 3' exoribonuclease	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	DDX6
Mu-calpain pathway	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	ITGB1
Prolactin receptor signaling pathway	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	PRLR
Sema3A/PAK-dependent axon repulsion	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	SEMA3A
Signaling to p38 via RIT and RIN	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	RIT2
TRAF6-mediated induction of TAK1 complex	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	MAP3K7
TrkA receptor signaling pathway	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	PIK3CA
Glycerophospholipid metabolism	3/79	0.3164279982103083	1.0	0	0	1.5189873417721518	1.747837301901023	CDS1;PCYT1B;AGPAT4
Signaling by NGF	7/221	0.3164880923086353	1.0	0	0	1.2669683257918551	1.4576086204528695	FGD4;RIT2;CREB1;PIK3CA;PRKAR1A;IRS1;FRS2
Calcium regulation in the cardiac cell	5/149	0.316701376398177	1.0	0	0	1.3422818791946307	1.5433503078978634	GNG2;PRKAR1A;CACNA1A;RYR3;GNAI1
Syndecan 1 pathway	2/46	0.3199619156443703	1.0	0	0	1.7391304347826086	1.981831832838938	COL11A1;COL4A6
Agrin in postsynaptic differentiation	2/47	0.32917493125894143	1.0	0	0	1.7021276595744679	1.891346320966911	ITGB1;LAMC1
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	2/47	0.32917493125894143	1.0	0	0	1.7021276595744679	1.891346320966911	SUGT1;MAP3K7
Regulation of transcription by NOTCH1 intracellular domain	2/47	0.32917493125894143	1.0	0	0	1.7021276595744679	1.891346320966911	HEY1;HIF1A
CXCR4 signaling pathway	4/116	0.32999523901017713	1.0	0	0	1.379310344827586	1.5292097267138929	ITGB1;GNG2;PIK3CA;GNAI1
CRMPs in Sema3A signaling	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	SEMA3A
Inhibition of platelet activation by aspirin	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	ITGB1
Inhibitor of DNA binding (ID) signaling pathway	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	RB1
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	MAP3K7
KIT signaling regulation	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	KITLG
Nucleotide-like (purinergic) G-protein coupled receptors	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	LPAR4
Other semaphorin interactions	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	ITGB1
PI3K subunit p85 role in regulation of actin organization and cell migration	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	PIK3CA
Rb tumor suppressor/checkpoint signaling in response to DNA damage	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	RB1
Sprouty regulation of FGF signaling	1/16	0.33318195100730313	1.0	0	0	2.5	2.7476663470054308	SPRY2
ATM-dependent DNA damage response	3/82	0.33702536869684624	1.0	0	0	1.4634146341463412	1.5916054733134235	IRS1;CTNNB1;MAP3K7
Chondroitin sulfate/dermatan sulfate metabolism	2/48	0.3383532866029959	1.0	0	0	1.6666666666666665	1.8061078378867632	GPC3;GPC4
Energy metabolism	2/48	0.3383532866029959	1.0	0	0	1.6666666666666665	1.8061078378867632	ATF2;CREB1
Generic transcription pathway	11/377	0.3438017342233863	1.0	0	0	1.16710875331565	1.2461105102843184	MED23;TGIF1;ZNF154;NCOA2;MED13;CHD9;NCOA3;ESRRB;RORB;MED4;E2F5
Deadenylation-dependent mRNA decay	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	DDX6;DIS3
Apoptotic cleavage of cellular proteins	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	SATB1
Atypical NF-kappaB pathway	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	PIK3CA
Beta-catenin phosphorylation cascade	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	CTNNB1
Branched-chain amino acid catabolism	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	BCKDHB
Cell to cell adhesion signaling	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	CTNNB1
Cells and molecules involved in local acute inflammatory response	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	ITGB1
Chromatin remodeling by hSWI/SNF ATP-dependent complexes	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	SMARCE1
Destabilization of mRNA by KSRP	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	DIS3
Endocytotic role of NDK, phosphins and dynamin	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	PICALM
Eukaryotic protein translation	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	EIF3A
Glycosylphosphatidylinositol (GPI) biosynthesis	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	PIGN
Inflammasomes	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	SUGT1
Insulin-like growth factor (IGF) activity regulation by insulin-like growth factor binding proteins (IGFBPs)	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	IGF2
Integrin beta-5 pathway	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	FBN1
Nitric oxide metabolism	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	ZDHHC21
SHC1 events in EGFR signaling	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	IRS1
Synaptic proteins at the synaptic junction	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	DLG2
TAK1-mediated activation of p38 MAPK	1/17	0.3498657220916832	1.0	0	0	2.352941176470588	2.4710725865370216	MAP3K7
Phosphatidylinositol metabolism	2/50	0.3565901556321914	1.0	0	0	1.5999999999999999	1.6498690882006875	PIK3CA;PIP5K1B
Translation factors	2/50	0.3565901556321914	1.0	0	0	1.5999999999999999	1.6498690882006875	GSPT2;EIF3A
Integrin cell surface interactions	3/85	0.3575874776802259	1.0	0	0	1.4117647058823528	1.4518238879557512	ITGB1;LAMC1;FBN1
Signaling by PDGF	4/122	0.3641152134210863	1.0	0	0	1.3114754098360655	1.3249638571013858	CREB1;PIK3CA;PRKAR1A;COL6A6
Glycerophospholipid biosynthesis	3/86	0.36442414082249097	1.0	0	0	1.3953488372093021	1.4085165595114748	CDS1;PCYT1B;AGPAT4
Progesterone-mediated oocyte maturation	3/86	0.36442414082249097	1.0	0	0	1.3953488372093021	1.4085165595114748	PIK3CA;PDE3B;GNAI1
Nuclear receptor transcription pathway	2/51	0.36564128501908433	1.0	0	0	1.5686274509803921	1.578200034140809	ESRRB;RORB
Botulinum neurotoxicity	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	STX7
CBL signaling regulation	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	PIK3CA
CDK regulation of DNA replication	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	KITLG
Corticosteroids and cardioprotection	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	PIK3CA
Nicotinic acetylcholine receptor role in the regulation of apoptosis	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	PIK3CA
Phosphatidylcholine biosynthesis	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	PCYT1B
Serotonin receptor 4/6/7 and NR3C signaling	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	CREB1
Transcriptional activity regulation by PML	1/18	0.3661328787804519	1.0	0	0	2.222222222222222	2.232797677094987	RB1
Class C GPCRs (metabotropic glutamate and pheromone receptors)	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	GRM3
Destabilization of mRNA by butyrate response factor 1 (BRF1)	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	DIS3
ER-associated degradation (ERAD) pathway	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	MAN1A1
FRS2-mediated activation	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	FRS2
GABA biosynthesis, release, reuptake and degradation	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	SLC6A1
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	HIF1A
Inhibition of T cell receptor signaling by activated Csk	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	PRKAR1A
Mitochondrial gene expression	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	CREB1
Ras activation upon calcium influx through NMDA receptor	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	CREB1
Signaling by FGFR1 fusion mutants	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	PIK3CA
Telomeres, telomerase, cellular aging, and immortality	1/19	0.3819938041881401	1.0	0	0	2.1052631578947367	2.0260018734944683	RB1
Amyotrophic lateral sclerosis (ALS)	2/53	0.38359202335177106	1.0	0	0	1.5094339622641508	1.4463029892393837	GRIA2;PRPH
Gap junction pathway	3/90	0.39163344766088204	1.0	0	0	1.3333333333333333	1.2499052788690577	TJP1;DRD1;GNAI1
Kit receptor signaling pathway	2/54	0.3924854550749619	1.0	0	0	1.4814814814814814	1.385564147526165	KITLG;GRB10
Non-small cell lung cancer	2/54	0.3924854550749619	1.0	0	0	1.4814814814814814	1.385564147526165	RB1;PIK3CA
RANKL signaling pathway	2/54	0.3924854550749619	1.0	0	0	1.4814814814814814	1.385564147526165	CALCR;MAP3K7
4-1BB-dependent immune response	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	ATF2
Acute myocardial infarction	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	COL4A6
GATA3-mediated activation of Th2 cytokine expression	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	PRKAR1A
Gene expression regulation in pancreatic beta cells	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	PAX6
Hypertrophy pathway	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	ADAM10
ID regulation of gene expression	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	ISL1
Interleukin-3 regulation of hematopoietic cells	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	CYSLTR2
Nerve growth factor (NGF) pathway	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	PIK3CA
Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	PIK3CA
Sprouty regulation of tyrosine kinase signals	1/20	0.39745862307532415	1.0	0	0	2.0	1.8453288863961157	SPRY2
Phospholipid metabolism	6/205	0.40632024639484465	1.0	0	0	1.170731707317073	1.0543769515123116	CDS1;PCYT1B;ASAH2;PIK3CA;PIP5K1B;AGPAT4
Thromboxane A2 receptor signaling	2/56	0.41009437639646396	1.0	0	0	1.4285714285714284	1.273382799199648	GNG2;RAB11A
Signaling by ERBB4	3/93	0.41184736294433893	1.0	0	0	1.2903225806451613	1.1446483568607568	CREB1;PIK3CA;PRLR
CD28-dependent PI3K/Akt signaling	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	PIK3CA
ChREBP regulation by carbohydrates and cAMP	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	PRKAR1A
Oxidative stress-induced gene expression via Nrf2	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	CREB1
PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	CACNA1A
Presynaptic function of kainate receptors	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	GNG2
Prion pathway	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	LAMC1
S1P/S1P1 pathway	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	GNAI1
T cell activation co-stimulatory signal	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	PIK3CA
p38 MK2 pathway	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	CREB1
Cell surface interactions at the vascular wall	3/94	0.418539889978251	1.0	0	0	1.276595744680851	1.1118932898382732	ITGB1;ANGPT4;PIK3CA
ERBB signaling pathway	3/94	0.418539889978251	1.0	0	0	1.276595744680851	1.1118932898382732	PIK3CA;GAB1;CBLB
Fc gamma receptor-mediated phagocytosis	3/94	0.418539889978251	1.0	0	0	1.276595744680851	1.1118932898382732	PIK3CA;PIP5K1B;DNM1L
Inositol phosphate metabolism	2/57	0.41880475936093825	1.0	0	0	1.4035087719298245	1.2215444712550116	PIK3CA;PIP5K1B
Pathogenic Escherichia coli infection	2/57	0.41880475936093825	1.0	0	0	1.4035087719298245	1.2215444712550116	ITGB1;CTNNB1
G-protein signaling pathways	3/95	0.42520717958043197	1.0	0	0	1.263157894736842	1.0802257862809745	AKAP11;PRKAR1A;GNAI1
Transport of inorganic cations/anions and amino acids/oligopeptides	3/95	0.42520717958043197	1.0	0	0	1.263157894736842	1.0802257862809745	SLC17A6;SLC17A8;SLC38A4
AKT signaling pathway	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	PIK3CA
Epstein-Barr virus LMP1 signaling	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	MAP3K7
Nephrin interactions	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	PIK3CA
Nitric oxide signaling pathway	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	PRKAR1A
Smooth muscle contraction	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	CALD1
T cell receptor downstream signaling	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	MAP3K7
HIV-1 Nef as negative effector of Fas and TNF	2/58	0.4274492922819714	1.0	0	0	1.379310344827586	1.1723029133595582	RB1;CFLAR
Cyclins and cell cycle regulation	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	RB1
Downregulation of SMAD2/3-SMAD4 transcriptional activity	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	TGIF1
FGFR ligand binding and activation	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	FGF19
Hypoxia and p53 in the cardiovascular system	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	HIF1A
Modulation of interferon signaling by chaperones	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	RB1
Post-elongation processing of intronless pre-mRNA	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	PAPOLA
Progesterone-initiated oocyte maturation	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	PRKAR1A
Rho cell motility signaling pathway	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	PIP5K1B
Signaling events mediated by PRL	1/23	0.4415739476417069	1.0	0	0	1.7391304347826086	1.4215822280628116	ITGB1
Ubiquitin-mediated proteolysis	4/136	0.4430281180785562	1.0	0	0	1.176470588235294	0.9577906341066323	KLHL9;HERC4;CBLB;RNF7
Class A GPCRs (rhodopsin-like)	7/253	0.4467078492012627	1.0	0	0	1.1067193675889326	0.8918503327680175	LHCGR;CYSLTR2;OPN3;PTGER3;LPAR4;DRD1;F2RL2
Granule cell survival pathway	3/99	0.45159604781162715	1.0	0	0	1.2121212121212122	0.9635966039626941	CREB1;PLCH1;KCNK1
Ion channel transport	2/61	0.4529669891745948	1.0	0	0	1.3114754098360655	1.0386046265359035	GABRA2;GLRA2
Cholesterol biosynthesis	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	SQLE
Inhibition of cellular proliferation by Gleevec	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	PIK3CA
NF-kappaB signaling pathway	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	MAP3K7
SREBP signaling	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	CREB1
Sulfur amino acid metabolism	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	CTH
TAK1 activates NF-kappaB by phosphorylation and activation of IKK complex	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	MAP3K7
Triacylglyceride biosynthesis	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	AGPAT4
Interleukin-2 signaling pathway	22/847	0.45794638618991845	1.0	0	0	1.0389610389610389	0.8114318570813455	GRIA2;NFAT5;IRS1;PLAG1;PTGER3;BCKDHB;PDE3B;RRAS2;RAB27B;DNAJC13;CFLAR;TRH;TIAL1;SQLE;ZEB2;ELF1;RAB31;MMP16;PIK3CA;INPP5F;MYB;GPC3
T cell receptor signaling pathway	4/139	0.4596056772594075	1.0	0	0	1.1510791366906474	0.8948332437112545	NFAT5;PIK3CA;CBLB;MAP3K7
Signaling events mediated by focal adhesion kinase	2/62	0.46132803795917154	1.0	0	0	1.2903225806451613	0.9982527870331739	ITGB1;PIK3CA
TNF-alpha signaling pathway	3/101	0.4646041358021239	1.0	0	0	1.188118811881188	0.9107757110849387	NRK;CFLAR;MAP3K7
Alpha-9 beta-1 integrin pathway	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	ITGB1
Basigin interactions	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	ITGB1
Cellular response to hypoxia	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	HIF1A
DARPP-32 events	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	PRKAR1A
G0 and early G1 pathway	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	E2F5
Glutathione conjugation	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	GSTA4
IGF1 receptor signaling through beta-arrestin	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	PIK3CA
Maturity onset diabetes of the young	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	PAX6
Regulatory RNA pathways	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	AGO3
TPO signaling pathway	1/25	0.4691782022031496	1.0	0	0	1.5999999999999999	1.2108361930392557	PIK3CA
Endothelins	2/64	0.47782308073315993	1.0	0	0	1.25	0.9231434237408449	CYSLTR2;GNAI1
ERBB2 role in signal transduction and oncology	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	PIK3CA
Glycosaminoglycan biosynthesis: heparan sulfate	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	NDST3
Inhibition of activated T cell apoptosis by neuropeptides VIP and PACAP	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	PRKAR1A
Integrin family cell surface interactions	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	ITGB1
Physiological and pathological hypertrophy  of the heart	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	LIFR
Ras signaling pathway	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	PIK3CA
Selenoamino acid metabolism	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	CTH
Termination of O-glycan biosynthesis	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	ST6GALNAC3
Chagas disease	3/104	0.4838567938447761	1.0	0	0	1.1538461538461537	0.8376534190762757	PIK3CA;CFLAR;GNAI1
ERK1/ERK2 MAPK pathway	2/65	0.48595425402499	1.0	0	0	1.2307692307692308	0.8881732763477085	ITGB1;CREB1
Glioma	2/65	0.48595425402499	1.0	0	0	1.2307692307692308	0.8881732763477085	RB1;PIK3CA
Endochondral ossification	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	IGF2;GLI3
Semaphorin interactions	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	ITGB1;SEMA3A
Signaling by TGF-beta receptor complex	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	TGIF1;E2F5
Bile acid and bile salt metabolism	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	ABCB11
CTCF pathway	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	PIK3CA
EGFR downregulation	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	SPRY2
FSH signaling pathway	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	CREB1
Glucuronidation	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	SLC35D1
Proteins and DNA sequences in cardicac structures	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	TFAP2B
RNA polymerase III transcription initiation from type 2 promoter	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	BDP1
TWEAK regulation of gene expression	1/27	0.49542050679657673	1.0	0	0	1.4814814814814814	1.0405161012766946	MMP16
Adipocytokine signaling pathway	2/67	0.5019777233846834	1.0	0	0	1.1940298507462686	0.8229248191077754	IRS1;IRS4
SIDS susceptibility pathways	2/67	0.5019777233846834	1.0	0	0	1.1940298507462686	0.8229248191077754	REST;CREB1
cAMP cell motility pathway inferred from amoeba model	2/67	0.5019777233846834	1.0	0	0	1.1940298507462686	0.8229248191077754	PDE3B;PLCH1
Cell cycle: G1/S checkpoint	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	RB1
G-protein beta-gamma signalling	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	GNG2
Interleukin receptor SHC signaling	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	PIK3CA
Messenger RNA capping	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	GTF2F2
Nitric oxide stimulation of guanylate cyclase	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	PDE3B
PERK-regulated gene expression	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	DIS3
PKB-mediated events	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	PDE3B
Phosphatidic acid biosynthesis	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	AGPAT4
RNA polymerase III transcription initiation From type 3 promoter	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	BDP1
NFAT involvement in hypertrophy of the heart	2/69	0.5176757123539347	1.0	0	0	1.1594202898550725	0.7633695892092621	PIK3CA;PRKAR1A
Association of TriC/CCT with target proteins during biosynthesis	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	KIF13A
CDO in myogenesis	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	CTNNB1
Matrix metalloproteinases	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	MMP16
Post-translational modification: biosynthesis of GPI-anchored proteins	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	PIGN
Skeletal myogenesis control by HDAC and calcium/calmodulin-dependent kinase (CaMK)	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	PIK3CA
Statin pathway	1/29	0.5203679297086519	1.0	0	0	1.379310344827586	0.9009919454829998	SQLE
Hedgehog signaling pathway	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	HHIP;GLI3
MicroRNA regulation of DNA damage response	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	RB1;CREB1
NCAM signaling for neurite out-growth	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	CREB1;COL6A6
Pancreatic cancer	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	RB1;PIK3CA
Activation of matrix metalloproteinases	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	MMP16
Gap junction trafficking and regulation	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	TJP1
Inflammatory response pathway	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	LAMC1
MicroRNAs in muscle cell differentiation	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	PRKAR1A
PDGFA signaling pathway	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	PIK3CA
Signaling by FGFR1 mutants	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	PIK3CA
Tight junction interactions	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	CLDN2
Interleukin-6 signaling pathway	2/71	0.533041249161984	1.0	0	0	1.1267605633802817	0.7089086955075764	PIK3CA;GAB1
Phase II of biological oxidations: conjugation	2/71	0.533041249161984	1.0	0	0	1.1267605633802817	0.7089086955075764	SLC35D1;GSTA4
Leishmaniasis	2/72	0.5405975770602098	1.0	0	0	1.111111111111111	0.6834223634393684	ITGB1;MAP3K7
Myocyte adrenergic pathway	2/72	0.5405975770602098	1.0	0	0	1.111111111111111	0.6834223634393684	RYR3;GNAI1
Alpha-V beta-3 integrin/OPN pathway	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	PIK3CA
Amino acid transport across the plasma membrane	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	SLC38A4
CD28 co-stimulation	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	PIK3CA
CD40/CD40L signaling	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	CBLB
Inwardly rectifying potassium channels	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	GNG2
NF-kappaB activation by non-typeable Hemophilus influenzae	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	MAP3K7
One-carbon metabolism	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	ALDH1L2
Prostaglandin biosynthesis and regulation	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	PTGER3
Transport of vitamins, nucleosides, and related molecules	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	SLC35D1
E2F transcription factor network	2/74	0.5554545611303542	1.0	0	0	1.0810810810810811	0.635641590695438	RB1;E2F5
Alpha-synuclein signaling	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	SNCA
Glycine, serine and threonine metabolism	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	CTH
Netrin-mediated signaling events	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	PIK3CA
Prothrombin activation intrinsic pathway	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	COL4A6
Signaling by Robo receptor	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	SRGAP1
Syndecan 4 pathway	1/32	0.5554998006860319	1.0	0	0	1.25	0.7348587858794243	ITGB1
G alpha (i) signaling events	5/199	0.5581355275127633	1.0	0	0	1.0050251256281406	0.5860838846676963	OPN3;GNG2;PTGER3;S1PR3;GNAI1
E2F-mediated regulation of DNA replication	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	RB1
Glucagon-type ligand receptors	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	GNG2
Glycoprotein VI-mediated activation cascade	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	PIK3CA
Syndecan 2 pathway	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	ITGB1
Endocytosis	5/201	0.5670425168236146	1.0	0	0	0.9950248756218906	0.564498499986165	RAB31;CBLB;PIP5K1B;DNM1L;RAB11A
VEGF signaling pathway	2/76	0.5699678510175187	1.0	0	0	1.0526315789473684	0.5917634962819259	NFAT5;PIK3CA
EPO receptor signaling	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	IRS1
Induction of apoptosis through DR3 and DR4/5 death receptors	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	CFLAR
Monoamine transport	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	SLC6A1
Nuclear receptors in lipid metabolism and toxicity	1/34	0.5774822066735724	1.0	0	0	1.176470588235294	0.6459737035478923	ABCB11
Arf6 signal transduction regulation	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	LHCGR
Basal transcription factors	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	GTF2F2
Integrated cancer pathway	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	RB1
Interleukin-7 signaling pathway	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	PIK3CA
Prion diseases	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	LAMC1
Signal transduction by L1	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	ITGB1
Unfolded protein response	2/79	0.591088531821221	1.0	0	0	1.0126582278481011	0.5324450357053537	SERP1;DIS3
GM-CSF-mediated signaling events	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	PIK3CA
SNARE interactions in vesicular transport	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	STX7
Transport to the Golgi and subsequent modification	1/36	0.5983795526602211	1.0	0	0	1.111111111111111	0.5705889143615132	MAN1A1
Factors involved in megakaryocyte development and platelet production	3/125	0.608029043614279	1.0	0	0	0.96	0.4776313238922669	PRKAR1A;MYB;CAPZA2
Interleukin-1 signaling pathway	3/125	0.608029043614279	1.0	0	0	0.96	0.4776313238922669	ATF2;PIK3CA;MAP3K7
FRA pathway	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	DMTF1
Interleukin-23-mediated signaling events	1/37	0.6084381377362886	1.0	0	0	1.0810810810810811	0.5371459840670496	PIK3CA
Platelet homeostasis	2/82	0.611427375574375	1.0	0	0	0.975609756097561	0.4799600929754372	GNG2;PDE3B
Regular glucocorticoid receptor pathway	2/82	0.611427375574375	1.0	0	0	0.975609756097561	0.4799600929754372	NCOA2;CREB1
T cell signal transduction	2/83	0.6180333278447322	1.0	0	0	0.963855421686747	0.4638196572792209	NFAT5;CBLB
Glycosphingolipid metabolism	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	ASAH2
Signal transduction through IL-1R	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	MAP3K7
Signaling events mediated by HDAC class II	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	GNG2
Triglyceride biosynthesis	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	AGPAT4
Differentiation pathway in PC12 cells	2/84	0.6245526523539249	1.0	0	0	0.9523809523809523	0.44830442071927945	FRS2;PLCH1
Angiotensin II-mediated activation of JNK pathway via Pyk2-dependent signaling	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	ATF2
Aurora B signaling	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	KLHL9
G13 signaling pathway	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	PIK3CA
HIV-1 transcription initiation	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	GTF2F2
Tricarboxylic acid (TCA) cycle	1/39	0.6278072988155387	1.0	0	0	1.0256410256410255	0.4774584703811021	IDH1
PDGFB signaling pathway	3/129	0.62930752214775	1.0	0	0	0.9302325581395349	0.43082347471841215	PIK3CA;GRB10;GAB1
MicroRNAs in cardiomyocyte hypertrophy	2/85	0.6309855429295065	1.0	0	0	0.9411764705882353	0.433385720533733	PIK3CA;CTNNB1
NOD signaling pathway	2/85	0.6309855429295065	1.0	0	0	0.9411764705882353	0.433385720533733	SUGT1;MAP3K7
Nuclear signaling by ErbB4	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	PRLR
PAC1 receptor pathway	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	PLCH1
Pyruvate metabolism and citric acid (TCA) cycle	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	IDH1
Parkinson's disease	3/131	0.6396436458477918	1.0	0	0	0.916030534351145	0.4093228040279114	SNCAIP;SLC18A2;SNCA
FOXM1 transcription factor network	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	RB1
Fc epsilon receptor I signaling in mast cells	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	PIK3CA
T cell receptor regulation of apoptosis	14/603	0.6494173577376117	1.0	0	0	0.9286898839137644	0.4008965619240497	RB1;CRB1;NDFIP1;SATB1;RYK;LEF1;PDE3B;CFLAR;GNAI1;RCBTB2;CTH;MYB;TRIM13;BPTF
Amine ligand-binding G-protein coupled receptors	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	DRD1
Bladder cancer	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	RB1
Eukaryotic transcription initiation	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	GTF2F2
Messenger RNA splicing: minor pathway	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	GTF2F2
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	ITGB1
Cleavage of growing transcript in the termination region	1/43	0.6637238288168202	1.0	0	0	0.9302325581395349	0.38129221998251456	PAPOLA
Adrenergic pathway	3/137	0.6694281778392484	1.0	0	0	0.8759124087591241	0.35153115058518086	PDE3B;PLCH1;GNAI1
Diabetes pathways	3/137	0.6694281778392484	1.0	0	0	0.8759124087591241	0.35153115058518086	SERP1;DIS3;IGF2
Actin cytoskeleton regulation	5/226	0.6698864251668236	1.0	0	0	0.8849557522123893	0.35455495189623415	ITGB1;PIK3CA;FGF19;RRAS2;PIP5K1B
ERBB2/ERBB3 signaling events	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	PIK3CA
NCAM1 interactions	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	COL6A6
Valine, leucine and isoleucine degradation	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	BCKDHB
MAPK signaling pathway	7/314	0.6727815293034672	1.0	0	0	0.8917197452229298	0.3534194100906634	ATF2;CREB1;FGF19;RRAS2;RAPGEF2;CACNA1A;MAP3K7
p53 signaling pathway	3/139	0.678947280053301	1.0	0	0	0.8633093525179856	0.3342835665780219	RB1;DKK1;POU4F1
HNF3B pathway	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	CREB1
Interleukin-3, interleukin-5, and GM-CSF signaling	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	PIK3CA
RNA polymerase III transcription	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	BDP1
Wnt interactions in lipid metabolism and immune response	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	DKK1
EGF/EGFR signaling pathway	3/141	0.6882620673272747	1.0	0	0	0.8510638297872339	0.31794519299096285	CREB1;GAB1;SPRY2
RhoA activity regulation	1/46	0.688372038071095	1.0	0	0	0.8695652173913043	0.32471811668930733	SRGAP1
ABC transporters	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	ABCB11
LKB1 signaling events	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	CREB1
Regulation of NFAT transcription factors	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	CBLB
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family	2/97	0.7015629289067601	1.0	0	0	0.8247422680412371	0.29232550701224613	CAPN6;HIF1A
Activation of chaperones by IRE1 alpha	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	SERP1
Diurnally regulated genes with circadian orthologs	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	RBPMS
N-glycan biosynthesis	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	MAN1A1
Downstream signaling events Of B cell receptor (BCR)	2/98	0.7069070769803031	1.0	0	0	0.8163265306122448	0.283147799645867	CREB1;MAP3K7
FoxO family signaling	1/49	0.7112169323217401	1.0	0	0	0.8163265306122448	0.27818594854238055	CTNNB1
Glycerolipid metabolism	1/49	0.7112169323217401	1.0	0	0	0.8163265306122448	0.27818594854238055	AGPAT4
Muscle contraction	1/49	0.7112169323217401	1.0	0	0	0.8163265306122448	0.27818594854238055	CALD1
Senescence and autophagy	2/99	0.712171216084855	1.0	0	0	0.8080808080808081	0.27429246420172493	RB1;RB1CC1
Disease	15/674	0.7139953763581692	1.0	0	0	0.8902077151335311	0.29989210001693645	DIS3;STX7;IGF2;GAB1;ADAM10;FRS2;IL17RD;GTF2F2;SERP1;CREB1;PIK3CA;PRKAR1A;FGF19;SPRY2;SNCA
Integrin-mediated cell adhesion	2/100	0.7173559974425507	1.0	0	0	0.7999999999999999	0.2657464415359102	ITGB1;CAPN6
Pancreatic secretion	2/101	0.7224620897819041	1.0	0	0	0.792079207920792	0.2574972920889452	RAB27B;RAB11A
RNA polymerase II transcription	2/101	0.7224620897819041	1.0	0	0	0.792079207920792	0.2574972920889452	PAPOLA;GTF2F2
Amyloids	1/51	0.7255104548045064	1.0	0	0	0.7843137254901961	0.25167042845488546	SNCA
Signaling by the B cell receptor (BCR)	3/151	0.7317997732945651	1.0	0	0	0.7947019867549668	0.2481443731300127	CREB1;CBLB;MAP3K7
Taste transduction	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	CACNA1A
Vitamin B12 metabolism	1/52	0.7323902008010184	1.0	0	0	0.7692307692307693	0.23957065064915506	CTH
Hemostasis pathway	10/468	0.7366246168008797	1.0	0	0	0.8547008547008547	0.26126227011403413	ITGB1;ANGPT4;GNG2;PIK3CA;PRKAR1A;MYB;CAPZA2;PDE3B;GNAI1;F2RL2
Protein folding	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	KIF13A
Integrin signaling pathway	3/155	0.7478227718898713	1.0	0	0	0.7741935483870968	0.22497233423808818	ITGB1;CAPN6;PIK3CA
TAp63 pathway	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	TFAP2C
Vibrio cholerae infection	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	TJP1
Platelet activation, signaling and aggregation	4/205	0.757118371611701	1.0	0	0	0.7804878048780487	0.2171595460690251	GNG2;PIK3CA;GNAI1;F2RL2
Steroid hormone biosynthesis	1/56	0.758230644178816	1.0	0	0	0.7142857142857142	0.19769118550302078	HSD17B2
Signaling by interleukins	2/109	0.7605630710629657	1.0	0	0	0.7339449541284404	0.20087797214127237	PIK3CA;MAP3K7
Toll receptor cascades	3/159	0.7630720538840987	1.0	0	0	0.7547169811320754	0.20407759787454713	ATF2;CREB1;MAP3K7
Activation of mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1/57	0.7642918118808011	1.0	0	0	0.7017543859649122	0.18863551580170362	EIF3A
Pre-NOTCH expression and processing	1/57	0.7642918118808011	1.0	0	0	0.7017543859649122	0.18863551580170362	AGO3
Leptin influence on immune response	2/110	0.7649933455424145	1.0	0	0	0.7272727272727272	0.1948277409678554	LIFR;SNCA
Arachidonic acid metabolism	1/58	0.770201320910123	1.0	0	0	0.689655172413793	0.18007127074521875	GPX7
Caspase cascade in apoptosis	1/59	0.7759629585959883	1.0	0	0	0.6779661016949152	0.1719664364110286	SATB1
Natural killer cell receptor signaling pathway	1/60	0.7815804178020295	1.0	0	0	0.6666666666666666	0.1642914883710904	PIK3CA
RAGE pathway	1/60	0.7815804178020295	1.0	0	0	0.6666666666666666	0.1642914883710904	ITGB1
Selenium pathway	1/60	0.7815804178020295	1.0	0	0	0.6666666666666666	0.1642914883710904	CTH
Clathrin derived vesicle budding	1/61	0.787057299393142	1.0	0	0	0.6557377049180327	0.15701916449443715	PICALM
HIV genome transcription	1/61	0.787057299393142	1.0	0	0	0.6557377049180327	0.15701916449443715	GTF2F2
Protein processing in the endoplasmic reticulum	3/166	0.7879517398264984	1.0	0	0	0.7228915662650601	0.17227838665644046	ATXN3;NGLY1;MAN1A1
Shigellosis	1/62	0.7923971144117075	1.0	0	0	0.6451612903225806	0.15012426177080712	ITGB1
Signaling by GPCR	21/977	0.7925842329007375	1.0	0	0	0.8597748208802456	0.19986023817585455	FZD3;LHCGR;OPN3;CALCB;FZD5;PTGER3;PDE3B;TRH;LPAR4;GNAI1;GRM3;FGD4;GNG2;CYSLTR2;CREB1;CALCR;PIK3CA;PRKAR1A;S1PR3;DRD1;F2RL2
Folate metabolism	1/63	0.7976032864598676	1.0	0	0	0.6349206349206349	0.143583453909114	CTH
O-linked glycosylation of mucins	1/63	0.7976032864598676	1.0	0	0	0.6349206349206349	0.143583453909114	ST6GALNAC3
Alzheimer's disease	3/169	0.7979329900263389	1.0	0	0	0.7100591715976331	0.1602821236375946	ADAM10;RYR3;SNCA
p53 activity regulation	2/118	0.7979355607695873	1.0	0	0	0.6779661016949152	0.15303554963265298	RB1;SESN3
Angiotensin II-stimulated signaling through G-proteins and beta-arrestin	1/64	0.8026791537609369	1.0	0	0	0.625	0.13737512770713134	PLCH1
G alpha s pathway	2/120	0.8055060782966527	1.0	0	0	0.6666666666666666	0.1441896869343059	CREB1;PDE3B
Interleukin-1 regulation of extracellular matrix	2/120	0.8055060782966527	1.0	0	0	0.6666666666666666	0.1441896869343059	ATF2;NR2F2
Interleukin-12-mediated signaling events	1/65	0.8076279713191508	1.0	0	0	0.6153846153846154	0.13147923570947304	ATF2
Rho GTPase cycle	2/123	0.8163893540594057	1.0	0	0	0.6504065040650406	0.13194399234802529	FGD4;SRGAP1
Telomerase regulation	1/67	0.8171570734698834	1.0	0	0	0.5970149253731343	0.12055160967876961	NR2F2
p75 neurotrophin receptor-mediated signaling	2/124	0.8198943491236538	1.0	0	0	0.6451612903225806	0.12811599326250314	FGD4;PIK3CA
AMPK signaling	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	PIK3CA
Activation of NF-kappaB in B cells	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	MAP3K7
Messenger RNA splicing: major pathway	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	PAPOLA
Influenza viral RNA transcription and replication	2/125	0.8233393070687913	1.0	0	0	0.64	0.12440760480345983	GTF2F2;GSPT2
Long-term potentiation	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	GRIA2
Transcription	3/181	0.8340027666839884	1.0	0	0	0.6629834254143646	0.1203437961958012	PAPOLA;BDP1;GTF2F2
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family	1/71	0.8348251375727604	1.0	0	0	0.5633802816901409	0.10170872796755898	CAPN6
RIG-I-like receptor signaling pathway	1/71	0.8348251375727604	1.0	0	0	0.5633802816901409	0.10170872796755898	MAP3K7
Metabolism	35/1615	0.8355262539736676	1.0	0	0	0.8668730650154799	0.15577146236578546	CDS1;ASAH2;PIGN;CHD9;CACNA1A;ABCB11;GNAI1;AGPAT4;GNG2;MED13;NDST3;HSD17B2;GPC3;HAS2;PIP5K1B;MAN1A1;GPC4;CA14;TRDMT1;NCOA2;PCYT1B;NCOA3;IDH1;BCKDHB;PAX6;MED4;ISL1;MED23;SQLE;PIK3CA;GSTA4;CTH;CTNNB1;FAR2;ST6GALNAC3
Costimulation by the CD28 family	1/72	0.8389691786747109	1.0	0	0	0.5555555555555555	0.0975451716537232	PIK3CA
Cyclin A-Cdk2-associated events at S phase entry	1/72	0.8389691786747109	1.0	0	0	0.5555555555555555	0.0975451716537232	RB1
Sphingolipid metabolism	1/72	0.8389691786747109	1.0	0	0	0.5555555555555555	0.0975451716537232	ASAH2
Carbohydrate metabolism	4/235	0.8423229678285881	1.0	0	0	0.6808510638297872	0.11682843645403129	NDST3;GPC3;HAS2;GPC4
Cap-dependent translation initiation	1/73	0.8430094520012101	1.0	0	0	0.547945205479452	0.09357649792044484	EIF3A
Degradation of beta-catenin by the destruction complex	1/73	0.8430094520012101	1.0	0	0	0.547945205479452	0.09357649792044484	CTNNB1
Gastric acid secretion	1/74	0.8469485510129866	1.0	0	0	0.5405405405405406	0.08979206961117422	GNAI1
Seven transmembrane receptor signaling through beta-arrestin	1/74	0.8469485510129866	1.0	0	0	0.5405405405405406	0.08979206961117422	PDE3B
Cell adhesion molecules (CAMs)	2/133	0.8488334569866297	1.0	0	0	0.6015037593984962	0.09858181994056327	ITGB1;CLDN2
Membrane trafficking	2/133	0.8488334569866297	1.0	0	0	0.6015037593984962	0.09858181994056327	TJP1;PICALM
Mitotic G1-G1/S phases	2/135	0.8546621232629286	1.0	0	0	0.5925925925925926	0.09306611295930632	RB1;E2F5
TNF-alpha effects on cytokine activity, cell motility, and apoptosis	2/135	0.8546621232629286	1.0	0	0	0.5925925925925926	0.09306611295930632	RYK;CFLAR
Chemokine signaling pathway	3/189	0.8548546663729355	1.0	0	0	0.6349206349206349	0.099570670059763	GNG2;PIK3CA;GNAI1
Natural killer cell-mediated cytotoxicity	2/137	0.8602852133033936	1.0	0	0	0.583941605839416	0.08787813216937412	NFAT5;PIK3CA
Peptide G-protein coupled receptors	3/192	0.8620645380791544	1.0	0	0	0.625	0.09276571309977663	LHCGR;TRH;F2RL2
Capped intron-containing pre-mRNA processing	2/138	0.8630215586579438	1.0	0	0	0.5797101449275363	0.08540035196931281	PAPOLA;GTF2F2
Fc epsilon receptor I signaling pathway	1/79	0.8652127562704516	1.0	0	0	0.5063291139240506	0.07330624875311624	PIK3CA
p73 transcription factor network	1/79	0.8652127562704516	1.0	0	0	0.5063291139240506	0.07330624875311624	RB1
Biological oxidations	2/139	0.865708767874858	1.0	0	0	0.5755395683453237	0.08299667495615301	SLC35D1;GSTA4
Apoptosis modulation and signaling	1/80	0.868595756144096	1.0	0	0	0.5	0.07043872237547145	CFLAR
Post-translational protein modification	3/196	0.871187993280201	1.0	0	0	0.6122448979591836	0.08442703425080052	PIGN;MAN1A1;ST6GALNAC3
Antigen processing and presentation	1/81	0.8718940108877108	1.0	0	0	0.49382716049382713	0.06769748622604009	CREB1
Toll-like receptor signaling pathway regulation	2/142	0.8734829514627659	1.0	0	0	0.5633802816901409	0.07620657301387117	PIK3CA;MAP3K7
Drug metabolism: cytochrome P450	1/83	0.8782447070953916	1.0	0	0	0.4819277108433735	0.06256868168843485	GSTA4
Asparagine N-linked glycosylation	1/85	0.8842811683327172	1.0	0	0	0.47058823529411764	0.057873036795879476	MAN1A1
Messenger RNA processing	3/203	0.8858774092199286	1.0	0	0	0.5911330049261083	0.07163154813509763	CELF2;PAPOLA;GTF2F2
mRNA stability regulation by proteins that bind AU-rich elements	1/86	0.8871864408298141	1.0	0	0	0.46511627906976744	0.055674477287034875	DIS3
Gene expression	19/968	0.8887069963506439	1.0	0	0	0.7851239669421487	0.09263495984812896	TGIF1;ZNF154;NCOA2;DDX6;DIS3;CHD9;NCOA3;ESRRB;RORB;MED4;GTF2F2;GSPT2;MED23;MED13;AGO3;PAPOLA;BDP1;E2F5;EIF3A
DNA replication pre-Initiation	1/88	0.8927804067909452	1.0	0	0	0.45454545454545453	0.051552106088443475	RB1
HIF-1 degradation in normoxia	1/88	0.8927804067909452	1.0	0	0	0.45454545454545453	0.051552106088443475	HIF1A
Hematopoietic cell lineage	1/88	0.8927804067909452	1.0	0	0	0.45454545454545453	0.051552106088443475	KITLG
Translation	2/151	0.8943856512566336	1.0	0	0	0.5298013245033112	0.059135480572440106	GSPT2;EIF3A
Salivary secretion	1/89	0.8954726961455193	1.0	0	0	0.449438202247191	0.04961957214050512	RYR3
EGFR1 pathway	2/152	0.896499067373559	1.0	0	0	0.5263157894736842	0.05750422433404838	HAS2;SPRY2
Phagosome	2/154	0.900608395987011	1.0	0	0	0.5194805194805194	0.0543816875318291	ITGB1;STX7
Cytokine-cytokine receptor interaction	4/265	0.9009209033887309	1.0	0	0	0.6037735849056604	0.06299641528104402	KITLG;BMPR2;LIFR;PRLR
Innate immune system	5/319	0.9036391750509783	1.0	0	0	0.6269592476489028	0.06352673411367463	ATF2;CREB1;CAPZA2;SUGT1;MAP3K7
RNA polymerase I, RNA polymerase III, and mitochondrial transcription	1/95	0.9102671124337166	1.0	0	0	0.42105263157894735	0.039586186271934845	BDP1
Interferon-gamma signaling pathway	1/97	0.9147185646131074	1.0	0	0	0.41237113402061853	0.03675828481515323	PIK3CA
TSH regulation of gene expression	1/97	0.9147185646131074	1.0	0	0	0.41237113402061853	0.03675828481515323	LRRN3
Dilated cardiomyopathy	1/100	0.9209858941252744	1.0	0	0	0.39999999999999997	0.03292422346760427	ITGB1
Immune system signaling by interferons, interleukins, prolactin, and growth hormones	4/280	0.9222851439273717	1.0	0	0	0.5714285714285714	0.04622904943207664	PIK3CA;IRS1;MAP3K7;PRLR
Metapathway biotransformation	2/174	0.934102950279601	1.0	0	0	0.45977011494252873	0.03134189502936992	GSTA4;NDST3
Cytoplasmic ribosomal proteins	1/108	0.9355414383081698	1.0	0	0	0.37037037037037035	0.02467771810747774	EIF3A
G alpha i pathway	1/108	0.9355414383081698	1.0	0	0	0.37037037037037035	0.02467771810747774	GNAI1
S phase	1/112	0.941782260555401	1.0	0	0	0.3571428571428571	0.021421848939758598	RB1
Huntington's disease	2/184	0.9465367040664775	1.0	0	0	0.43478260869565216	0.023889361024428443	REST;CREB1
Vascular smooth muscle contraction	1/116	0.9474199195730735	1.0	0	0	0.3448275862068965	0.018625125240809375	CALD1
Tricarboxylic acid (TCA) cycle and respiratory electron transport	1/117	0.9487420365553102	1.0	0	0	0.3418803418803419	0.01798917741029584	IDH1
HIV life cycle	1/118	0.9500309723481404	1.0	0	0	0.3389830508474576	0.01737650591432978	GTF2F2
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell	1/119	0.9512875582335184	1.0	0	0	0.3361344537815126	0.016786180690548515	ITGB1
Amino acid metabolism	2/195	0.9576265078033966	1.0	0	0	0.41025641025641024	0.017763053793865464	CTH;BCKDHB
Protein metabolism	6/442	0.966641029471293	1.0	0	0	0.5429864253393665	0.018422483220254637	PIGN;KIF13A;MAN1A1;ST6GALNAC3;GSPT2;EIF3A
Influenza infection	1/142	0.9728927010915251	1.0	0	0	0.28169014084507044	0.007741261759857956	GTF2F2
Purine metabolism	1/164	0.9845355521909135	1.0	0	0	0.24390243902439024	0.0038012852754180254	PDE3B
Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins	2/255	0.9885101346407765	1.0	0	0	0.3137254901960784	0.0036255321973263973	KLHL9;CBLB
HIV infection	1/200	0.9938349118863171	1.0	0	0	0.19999999999999998	0.001236834148110478	GTF2F2
DNA replication	1/207	0.9948452256492291	1.0	0	0	0.19323671497584538	9.98667832725851E-4	RB1
Adaptive immune system	6/606	0.997940276507796	1.0	0	0	0.396039603960396	8.16573322736082E-4	ITGB1;KLHL9;CREB1;PIK3CA;CBLB;MAP3K7
Cell cycle	3/453	0.9992348561256997	1.0	0	0	0.2649006622516556	2.027647010004729E-4	RB1;KITLG;E2F5
Immune system	11/998	0.9995757148256246	1.0	0	0	0.4408817635270541	1.8709929045192367E-4	ITGB1;KLHL9;ATF2;CREB1;PIK3CA;IRS1;CAPZA2;CBLB;SUGT1;MAP3K7;PRLR
